10-Q

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ Quarterly Report Pursuant to Section 13 Or 15(d) Of The Securities Exchange Act of 1934

 For the quarterly period ended March 31, 2024

☐ Transition Report Under Section 13 Or 15(d) Of The Securities Exchange Act of 1934

For the transition period ________ to ________

COMMISSION FILE NUMBER 001-08675

 UNITED STATES ANTIMONY CORPORATION

(Exact name of registrant as specified in its charter) 

Montana	81-0305822
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
P.O. Box 643 Thompson Falls, MT	59873
(Address of principal executive office)	(Postal Code)

(406) 827-3523

(Registrant’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, $0.01 par value	UAMY	NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post filed). Yes ☒ No ☐

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “Accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☒	Smaller Reporting Company	☒
Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 15, 2024, there were 108,438,984 shares outstanding of the registrant’s $0.01 par value common stock.

Table of Contents

PART I - FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS	3
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION.	19
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	29
ITEM 4.	CONTROLS AND PROCEDURES	29
PART II - OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS.	30
ITEM 1A.	RISK FACTORS.	30
ITEM 2.	RECENT SALES OF UNREGISTERED SECURITIES.	30
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	30
ITEM 4.	MINE SAFETY DISCOSURES.	30
ITEM 5.	OTHER INFORMATION.	30
ITEM 6.	EXHIBITS.	31

2

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED)

	March 31, 2024			December 31, 2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	11,941,298		$	11,899,574
Certificates of deposit		22,216			72,898
Accounts receivable, net		1,057,742			625,256
Inventories, net		653,010			1,019,154
Prepaid expenses and other current assets		117,167			92,369
Current assets held for sale (Note 11)		215,110			366,955
Total current assets		14,006,543			14,076,206
Properties, plants and equipment, net		7,709,812			7,765,045
Restricted cash for reclamation bonds		55,060			55,061
Other assets		18,098			18,098
Non-current assets held for sale (Note 11)		6,215,574			6,180,585
Total assets	$	28,005,087		$	28,094,995
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$	403,441		$	330,147
Accrued liabilities		117,822			109,341
Accrued liabilities - directors		167,059			124,810
Royalties payable		52,527			153,429
Long-term debt, current portion		7,170			28,443
Current liabilities held for sale (Note 11)		158,103			151,288
Total current liabilities		906,122			897,458
Stock payable to directors		38,542			38,542
Asset retirement obligations		1,119,832			1,101,561
Non-current liabilities held for sale (Note 11)		536,466			536,466
Total liabilities		2,600,962			2,574,027
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS' EQUITY
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Series A: 0 shares issued and outstanding		-			-
Series B: 750,000 shares issued and outstanding (liquidation preference $969,375 and $967,500, respectively)		7,500			7,500
Series C: 177,904 shares issued and outstanding (liquidation preference $97,847 both years)		1,779			1,779
Series D: 0 shares issued and outstanding		-			-
Common stock, $0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares issued and outstanding, respectively		1,084,389			1,076,472
Additional paid-in capital		64,051,844			63,853,836
Accumulated deficit		(39,741,387	)		(39,418,619	)
Total stockholders' equity		25,404,125			25,520,968
Total liabilities and stockholders' equity	$	28,005,087		$	28,094,995

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

3

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
	For the three months ended
	March 31, 2024			March 31, 2023
REVENUES	$	2,831,390		$	2,210,844
COST OF REVENUES		2,008,486			1,816,001
GROSS PROFIT		822,904			394,843
OPERATING EXPENSES:
General and administrative		455,394			141,271
Salaries and benefits		241,605			127,692
Professional fees		177,157			46,004
Loss on disposal of property, plant and equipment		17,494			-
TOTAL OPERATING EXPENSES		891,650			314,967
INCOME (LOSS) FROM OPERATIONS		(68,746	)		79,876
OTHER INCOME (EXPENSE):
Interest and investment income		150,851			122,372
Trademark and licensing income		6,368			7,525
Other miscellaneous income (expense)		(2,372	)		83,608
TOTAL OTHER INCOME		154,847			213,505
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES		86,101			293,381
Income tax expense		-			-
INCOME FROM CONTINUING OPERATIONS		86,101			293,381
Discontinued operations:
Loss from discontinued operations before income taxes		(408,869	)		(1,100,365	)
Income tax expense		-			-
Loss from discontinued operations (Note 11)		(408,869	)		(1,100,365	)
Net loss		(322,768	)		(806,984	)
Preferred dividends		(1,875	)		(1,875	)
Net loss available to common stockholders	($324,643)			($808,859)
Basic and diluted earnings per common share:
Income from continuing operations	$	nil		$	nil
Loss from discontinued operations	$	nil		$	(0.01	)
Net loss	$	nil		$	(0.01	)
Weighted average shares outstanding:
Basic		107,908,306			107,260,472
Diluted		107,908,306			107,260,472

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

4

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

For the three months ended March 31, 2024 and 2023

	Total Preferred Stock						Common stock
	Shares			Amount			Shares			Amount			Additional Paid In Capital			Shares to be returned to treasury			Accumulated Deficit			Total
Balances, December 31, 2022		2,620,576		$	26,205			106,373,341		$	1,063,732		$	64,052,630		$	(202,980	)	$	(33,070,332	)	$	31,869,255
Conversion of Preferred Series D to common stock		(1,692,672	)		(16,926	)		1,692,672			16,927			(1	)		-			-			-
Common stock buyback and retirement		-			-			(418,696	)		(4,187	)		(198,793	)		202,980			-			-
Net loss		-			-			-			-			-			-			(806,984	)		(806,984	)
Balances, March 31, 2023		927,904		$	9,279			107,647,317		$	1,076,472		$	63,853,836		$	-		$	(33,877,316	)	$	31,062,271
Balances, December 31, 2023		927,904		$	9,279			107,647,317		$	1,076,472		$	63,853,836		$	-		$	(39,418,619	)	$	25,520,968
Share-based compensation		-			-			791,667			7,917			198,008			-			-			205,925
Net loss		-			-			-			-			-			-			(322,768	)		(322,768	)
Balances, March 31, 2024		927,904		$	9,279			108,438,984		$	1,084,389		$	64,051,844		$	-		$	(39,741,387	)	$	25,404,125

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

5

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
	March 31, 2024			March 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES OF CONTINUING OPERATIONS:
Net income from continuing operations	$	86,101		$	293,381
Adjustments to reconcile net income from continuing operations to net cash
provided (used) by operating activities of continuing operations:
Depreciation and amortization		106,147			69,332
Accretion of asset retirement obligation		18,271			375
Loss on disposal of property, plant, and equipment		17,494			-
Write down of inventory to net realizable value		80,143			-
Share-based compensation		205,925			-
Other non-cash items		(15,695	)		2,041
Changes in operating assets and liabilities:
Accounts receivable, net		(432,486	)		(919,819	)
Inventories, net		286,001			(76,504	)
Prepaid expenses and other current assets		(24,798	)		(141,852	)
Accounts payable		73,294			158,942
Accrued liabilities		8,481			(55,425	)
Accrued liabilities – directors		42,249			19,746
Royalties payable		(100,902	)		(419,191	)
Net cash provided (used) by operating activities of continuing operations		350,225			(1,068,974	)
CASH FLOWS FROM INVESTING ACTIVITIES OF CONTINUING OPERATIONS:
Proceeds from redemption of certificates of deposit		50,682			-
Purchases of properties, plant, and equipment		(52,713	)		(501,202	)
Net cash used by investing activities of continuing operations		(2,031	)		(501,202	)
CASH FLOWS FROM FINANCING ACTIVITIES OF CONTINUING OPERATIONS:
Payments on dividends payable		-			(787,730	)
Principal payments on long-term debt		(21,273	)		(23,022	)
Net cash used by financing activities of continuing operations		(21,273	)		(810,752	)
Net cash flows provided (used) by continuing operations		326,921			(2,380,928	)
CASH FLOWS FROM DISCONTINUED OPERATIONS:
Net cash used by operating activities		(285,198	)		(1,204,818	)
Net cash used by investing activities		-			(113,568	)
Net cash flows used by discontinued operations		(285,198	)		(1,318,386	)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH		41,723			(3,699,314	)
|CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD		11,954,635			19,117,666
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	$	11,996,358		$	15,418,352
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Common stock buyback and retirement		-		$	202,980
Conversion of Preferred Series D to Common Stock		-		$	16,926

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

6

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

 NOTE 1 - NATURE OF OPERATIONS

United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover certain amounts of precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.

Developments in the Current Period - Discontinued Operations

The Company has two subsidiaries in Mexico, US Antimony de Mexico, S.A. de C.V. (“USAMSA”) and Antimonio de Mexico, S.A. de C.V. (“ADM”). On March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary, operations, or assets. The USAMSA subsidiary primarily includes the Company’s Madero antimony and precious metals plant in Parras de la Fuente Coahuila, Mexico and its Puerto Blanco antimony and precious metals plant in San Luis de la Paz Guanajuato, Mexico. The Company intends to sell its USAMSA subsidiary, operations, or assets over the next year and has initiated an active search for buyers of its operations and/or existing assets. While the Company will maintain its existing Los Juarez mining claims and concessions in Mexico, which are included in our ADM subsidiary, there are presently no active operations at Los Juarez. See Note 11 for further information.

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of March 31, 2024, and its results of operations and cash flows for the three months ended March 31, 2024 and 2023. The Condensed Consolidated Balance Sheet as of December 31, 2023, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 12, 2024.

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements.

Reclassifications

Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. 

7

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Discontinued Operations

Disposal groups that meet the discontinued operations criteria by the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-20-45 are classified as discontinued operations and are excluded from continuing operations and segment results for all periods presented.

Share-Based Compensation

The Company’s share-based awards consist of restricted stock units (“RSUs”) and stock options granted to employees and non-employee directors.

RSUs are stock awards entitling the award recipient to a specified number of shares of the Company’s common stock as the award vests. Each of our RSU grants include a time-based vesting condition, which is the only vesting condition related to the RSU grants. The Company calculates the fair value of RSUs on the grant date using the closing market price of the Company’s common stock on the grant date. The Company expenses the grant date fair value of RSUs ratably over the requisite service period, other than RSUs that vest on the grant date, the grant date fair value of which is expensed on the grant date. The Company recognizes forfeitures as they occur.

Stock options grant award recipients the option to purchase a specified number of shares of the Company’s common stock at an exercise price per share specified in the grant agreement as the stock options vest. Stock option grants include either a time-based vesting condition or performance-based vesting conditions with a specified term to meet the performance condition. The Company calculates the fair value of stock options on the grant date using the Black-Scholes option-pricing model, which requires the Company to make estimates and assumptions, such as expected volatility, expected term, and risk-free interest rate. For time-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably over the requisite service period. For performance-based vesting stock option grants, the Company expenses the grant date fair value of the award based on the probability and timing of achieving the performance criteria. The Company recognizes forfeitures as they occur.

The expense related to employee and non-employee director share-based awards is recorded in “Salaries and benefits” and “General and administrative,” respectively, in the Condensed Consolidated Statements of Operations.

Recent Accounting Pronouncements

Management does not believe that any recently issued but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, amending reportable segment disclosure requirements to include disclosure of incremental segment information on an annual and interim basis. Among the disclosure enhancements are new disclosures regarding significant segment expenses that are regularly provided to the chief operating decision-maker and included within each reported measure of segment profit or loss, as well as other segment items bridging segment revenue to each reported measure of segment profit or loss. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, and are applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures. 

8

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

NOTE 3 – EARNINGS PER SHARE

Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through convertible preferred stock, stock options, RSUs, and warrants.

At March 31, 2024 and 2023, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive were as follows:

	March 31, 2024		March 31, 2023
Warrants		12,346,215		12,346,215
RSUs		225,695		-
Total possible dilution		12,571,910		12,346,215

NOTE 4 – REVENUE RECOGNITION

Products consist of the following:

· Antimony: includes antimony oxide, antimony metal, antimony trisulfide.

· Zeolite: includes coarse and fine zeolite crushed in various sizes.

· Precious metals: includes unrefined and refined gold and silver.

Sales of products for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024		March 31, 2023
Antimony product revenue	$	2,228,385	$	1,612,639
Zeolite product revenue		603,005		482,093
Precious metals product revenue		-		116,112
TOTAL REVENUES	$	2,831,390	$	2,210,844

Domestic and foreign revenues for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024		March 31, 2023
Domestic revenues	$	2,280,774	$	1,991,230
Foreign revenues		550,616		219,614
TOTAL REVENUES	$	2,831,390	$	2,210,844

9

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

The Company’s trade accounts receivable balance related to contracts with customers was $1,057,742 at March 31, 2024 and $625,256 at December 31, 2023, net of an allowance for doubtful accounts related to trade accounts receivables of $271,212 at March 31, 2024 and December 31, 2023. The Company’s products do not involve any warranty agreements and product returns are not typical.

NOTE 5– INVENTORIES

Inventories at March 31, 2024 and December 31, 2023 consisted primarily of finished antimony metal and oxide products, antimony ore and concentrates, and finished zeolite products. Inventories are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products and finished zeolite products costs include direct materials, direct labor, overhead, depreciation, and freight. Inventories at March 31, 2024 and December 31, 2023 were as follows:

	March 31, 2024		December 31, 2023
Antimony oxide inventory	$	136,245	$	252,927
Antimony metal inventory		90,631		237,429
Antimony ore and concentrates inventory		24,482		23,752
Total antimony inventory		251,358		514,108
Zeolite inventory		401,652		505,046
TOTAL INVENTORIES	$	653,010	$	1,019,154

At March 31, 2024 and December 31, 2023, inventories were valued at cost, except for the portion of inventory related to zeolite which was valued at net realizable value because costs were greater than the amount the Company expected to receive on the sale of zeolite inventory. The adjustment to inventory for net realizable value was $80,143 and $Nil for the three months ended March 31, 2024 and 2023, respectively.

Antimony oxide and metal inventory consisted of finished product held by the Company’s plants in Montana and Mexico. Antimony ore and concentrates were held primarily at its sites in Montana and Mexico. The Company’s zeolite inventory consisted primarily of saleable zeolite material at the Company’s plant located in Idaho.

10

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT

The major components of the Company’s properties, plants and equipment (“PP&E”) by segment at March 31, 2024 and December 31, 2023 were as follows:

March 31, 2024	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,368,804		$	234,174		$	7,357,423
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			18,590			-			18,590
PP&E, gross	$	4,645,890		$	1,420,958		$	8,100,076		$	234,174		$	14,401,098
Accumulated depreciation		(2,675,660	)		(239,047	)		(3,597,180	)		(179,399	)		(6,691,286	)
PP&E, net	$	1,970,230		$	1,181,911		$	4,502,896		$	54,775		$	7,709,812

December 31, 2023	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,336,808		$	234,174		$	7,325,427
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			8,951			-			8,951
PP&E, gross	$	4,645,890		$	1,420,958		$	8,058,441		$	234,174		$	14,359,463
Accumulated depreciation		(2,661,719	)		(235,024	)		(3,524,130	)		(173,545	)		(6,594,418	)
PP&E, net	$	1,984,171		$	1,185,934		$	4,534,311		$	60,629		$	7,765,045

11

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

NOTE 7 – LONG-TERM DEBT

Long-term debt at March 31, 2024 and December 31, 2023 was as follows:

	March 31, 2024			December 31, 2023
Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck	$	7,170		$	28,443
Total debt		7,170			28,443
Less current portion of debt		(7,170	)		(28,443	)
Long term portion of debt	$	-		$	-

The principal payments owed Caterpillar Financial Services of $7,170 at March 31, 2024 will be due in April 2024. 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

The Company follows U.S. GAAP guidance in determining its accruals and disclosures with respect to loss contingencies and evaluates such accruals and contingencies for each reporting period. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a loss could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred.

Historically, from time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At March 31, 2024 and December 31, 2023, the Company had no accrued liabilities relating to such assessments. However, during the first quarter of 2024, Bear River Zeolite Company (“BRZ”), a wholly owned subsidiary of the Company, received four significant and substantial citations from MSHA, all of which have been rectified by BRZ prior to the filing of this quarterly report.

On a combined basis, BRZ pays royalties ranging from 8% to 13% on the sale of zeolite products. At March 31, 2024 and December 31, 2023, the Company had accrued royalties payable of $52,527 and $153,429, respectively.

NOTE 9 – STOCKHOLDERS’ EQUITY

On January 25, 2023, the holders of 1,692,672 shares of Series D Preferred stock converted the preferred shares and the Company issued 1,692,672 shares of common stock.  The Company also paid the holders $787,730 for dividends payable as declared on November 28, 2022. 1,590,672 shares of the 1,692,672 shares of Series D Preferred stock that were converted and $740,261 of the $787,730 of dividends paid related to the estate of John Lawrence, who was a prior President and Chairman of the Company.

On January 26, 2023, in conjunction with its share repurchase plan, the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980.

12

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Stock option and RSU awards were granted on January 29, 2024 and March 1, 2024 in accordance with our 2023 Equity Incentive Plan, which was approved by the Company’s shareholders. No other equity grants were outstanding at March 31, 2024. The Company’s Board of Directors granted to an employee on January 29, 2024 100,000 RSUs, one-third of which vest each year beginning each anniversary subsequent to the grant date, and 200,000 stock options with performance-based vesting conditions and a 10-year term. The fair value of the RSUs granted on January 29, 2024 was $24,000 and the fair value of the stock options granted on January 29, 2024 was $48,000. The Company’s Board of Directors also granted 2,375,000 RSUs and 3,400,000 stock options to employees and non-employee directors on March 1, 2024 with the RSUs vesting one-third each year beginning on the grant date, 2,500,000 stock options vesting one-third each year beginning each anniversary subsequent to the grant date, and 900,000 stock options with performance-based vesting conditions and a 3-year term. The fair value of the RSUs granted on March 1, 2024 was $522,500 and the fair value of the stock options granted on March 1, 2024 was $544,000. One-third of the RSUs granted on March 1, 2024, which equates to 791,667 shares of the Company’s common stock, vested during the three months ended March 31, 2024. At March 31, 2024, 1,583,333 RSU’s are unvested from the March 1, 2024 grant and 100,000 RSUs are unvested from the January 29, 2024 grant. The Company expensed $205,925 and $nil during the three months ended March 31, 2024 and 2023, respectively, related to stock option and RSU grants.

The remaining unrecognized compensation expense for RSUs granted on January 29, 2024 was $22,667 at March 31, 2024, which is expected to be recognized over the next 2.83 years. The remaining unrecognized compensation expense for RSUs granted on March 1, 2024 was $333,819 at March 31, 2024, which is expected to be recognized over the next 2.92 years.

The remaining unrecognized compensation expense for stock options granted on January 29, 2024 was $47,200 at March 31, 2024, which is expected to be recognized over the next 8.33 years. These stock options had no intrinsic value at March 31, 2024. The remaining unrecognized compensation expense for stock options granted on March 1, 2024 was $528,889 at March 31, 2024, which is expected to be recognized over the next 2.92 years. The intrinsic value of these stock options at March 31, 2024 was $102,000.

The fair value of stock options granted on January 29, 2024 and March 1, 2024 and the key assumptions used in the Black-Scholes valuation model to calculate the fair value are as follows:

	Stock Options			Stock Options
	Granted On			Granted On
	January 29, 2024			March 1, 2024
Fair value per share of options granted	$	0.24		$	0.16
Options granted		200,000			3,400,000
Exercise price per share	$	0.25		$	0.22
Expected Term (in years)		10			3
Risk-free rate		4.08	%		4.32	%
Volatility		302.65	%		116.28	%

13

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Common stock warrants

No warrants were issued, expired, or exercised during the three months ended March 31, 2024 and 2023.

The composition of the Company’s warrants outstanding at March 31, 2024 and 2023 was as follows:

Number of warrants		Exercise Price		Expiration Date	Remaining life (years)
	2,285,715	$	0.46	7/31/2025		1.33
	804,000	$	0.46	1/27/2026		1.83
	7,650,000	$	0.85	8/3/2026		2..34
	1,606,500	$	0.85	2/1/2026		1.84
	12,346,215

NOTE 10 – BUSINESS SEGEMENTS

The Company is organized and managed with four business segments, which represent our operating units: United States antimony operations, Mexico antimony operations, precious metals recovery and United States zeolite operations. See Note 11 for the Mexico discontinued operations that are excluded from business segments.

Total assets by segment at March 31, 2024 and December 31, 2023 were as follows: 

Total Assets, Excluding Discontinued Operations	March 31, 2024		December 31, 2023
Antimony segment:
United States total assets	$	14,962,876	$	14,769,408
Mexico total assets		1,248,036		1,211,319
Subtotal antimony segment	$	16,210,912	$	15,980,727
Precious metals segment:
United States total assets	$	86,864	$	92,718
Mexico total assets		-		-
Subtotal precious metals segment	$	86,864	$	92,718
Zeolite segment		5,276,627		5,474,010
Total assets, excluding discontinued operations	$	21,574,403	$	21,547,455

14

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Total capital expenditures by segment for the three months ended March 31, 2024 and 2023 were as follows: 

Capital expenditures, Excluding Discontinued Operations	For the three months ended
	March 31, 2024		March 31, 2023
Antimony segment:
United States capital expenditures	$	-	$	3,550
Mexico capital expenditures		-		-
Subtotal antimony segment	$	-	$	3,550
Precious metals segment		-		-
Zeolite segment		52,713		497,652
Total capital expenditures, excluding discontinued operations	$	52,713	$	501,202

Selected segment operational information for the three months ended March 31, 2024 and 2023 were as follows:

Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2024	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	2,228,385	$	-	$	2,228,385	$	-	$	603,005	$	2,831,390
Depreciation and amortization		13,941		4,024		17,965		5,854		82,328		106,147
Income (loss) from operations	$	394,806	($26,197)		$	368,609	($5,854)		($431,501)		(68,746)
Other income												154,847
Income tax expense												-
NET INCOME											$	86,101
Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2023	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	1,612,639	$	-	$	1,612,639	$	116,112	$	482,093	$	2,210,844
Depreciation and amortization		8,280		4,024		12,304		5,854		51,174		69,332
Income (loss) from operations	$	62,072	($27,849)		$	34,223	$	110,258	($64,605)		$	79,876
Other income												213,505
Income tax expense												-
NET INCOME											$	293,381

15

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

NOTE 11 – DISCONTINUED OPERATIONS

As described in Note 1, on March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary, operations, or assets over the next year. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. Accordingly, the condensed consolidated financial statements and notes to the condensed consolidated financial statements reflect the results of USAMSA as a discontinued operation and are excluded from continuing operations and segment results for all periods presented.

Our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows report discontinued operations separate from continuing operations. Our Condensed Consolidated Statements of Equity combine the results of continuing and discontinued operations.

The key components of the loss from discontinued operations for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024			March 31, 2023
REVENUES	$	240,677		$	-
COST OF REVENUES		474,096			930,262
GROSS PROFIT LOSS		(233,419	)		(930,262	)
OPERATING EXPENSES:
General and administrative		44,892			14,323
Professional fees		35,151			38,802
Other operating expenses		88,246			108,345
TOTAL OPERATING EXPENSES		168,289			161,470
LOSS FROM OPERATIONS		(401,708	)		(1,091,732	)
OTHER EXPENSE:
Other miscellaneous expense		(7,161	)		(8,633	)
TOTAL OTHER EXPENSE		(7,161	)		(8,633	)
LOSS FROM DISCONTINUED OPERATIONS BEFORE TAX		(408,869	)		(1,100,365	)
Income tax expense		-			-
LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX	$	(408,869	)	$	(1,100,365	)

Depreciation and amortization expense of USAMSA totaled $nil and $154,909 for the three months ended March 31, 2024 and 2023, respectively.

Accretion of asset retirement obligation of USAMSA totaled $nil and $2,993 for the three months ended March 31, 2024 and 2023, respectively.

16

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Write down of inventory to net realizable value of USAMSA totaled $43,074 and $246,792 for the three months ended March 31, 2024 and 2023, respectively.

Capital expenditures of USAMSA totaled $nil and $113,568 for the three months ended March 31, 2024 and 2023, respectively.

The carrying amounts of major classes of assets and liabilities of USAMSA included in assets and liabilities of discontinued operations were as follows:

	March 31, 2024		December 31, 2023
ASSETS
CURRENT ASSETS
Inventories, net	$	215,110	$	366,955
Total current assets, discontinued operations		215,110		366,955
Properties, plants and equipment, net		5,689,446		5,689,446
IVA receivable and other assets, net		526,128		491,139
Total assets, discontinued operations	$	6,430,684	$	6,547,540
LIABILITIES
CURRENT LIABILITIES
Accounts payable	$	137,744	$	126,788
Accrued liabilities		20,359		24,500
Total current liabilities, discontinued operations		158,103		151,288
Asset retirement obligations		536,466		536,466
Total liabilities, discontinued operations	$	694,569	$	687,754

Mexican Tax Assessment

In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The assessment was settled in 2018 with no assessment due from the Company.

In early 2019, the Company was notified that SAT re-opened its assessment of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $795,000 USD as of December 31, 2021.

17

UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 31, 2024

Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believes the findings have no merit. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. The Company posted a guarantee of the amount in March 2020 as is required under the appeal process. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments.  In 2022, the Mexican court ruled against the Company in the above matter. The Company subsequently appealed the ruling.

As of December 31, 2023, the updated SAT assessment was approximately $22.4 million pesos, or approximately $1,320,000 USD, which includes $352,000 of unpaid income taxes and $968,000 of interest and penalties. Management, along with its legal counsel, assessed the possible outcomes for this tax audit and believes, based on discussions with its attorneys located in Mexico, that the most likely outcome will be that the Company will be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at December 31, 2023 or December 31, 2022 relating to this potential tax liability.

In March 2024, the Company received a favorable ruling from its appeal with no assessment due related to this audit of USAMSA’s 2013 income tax return by SAT. This ruling supports the Company’s position on this tax matter and had no impact on the Company’s financial statements at March 31, 2024 or December 31, 2023. Mexico’s lower court will issue a final ruling on this matter as to whether this decision can be appealed by the appropriate Mexican authorities.

Mexico Value Added Tax

USAMSA records a receivable for the Value Added Tax (“VAT” or “IVA”) it pays on certain goods and services representing amounts to be reimbursed from the Mexican government. USAMSA has a reserve of $717,647 and $687,534 on its IVA receivable balance at March 31, 2024 and December 31, 2023, respectively. The net IVA receivable of $470,083 and $435,094 at March 31, 2024 and December 31, 2023, respectively, is recorded in “IVA receivable and other assets, net” in assets held for sale in discontinued operations.

18

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Readers should note that, in addition to the historical information contained herein, this Quarterly Report and the exhibits attached hereto contain “forward-looking statements” within the meaning of, and intended to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon current expectations and beliefs concerning future developments and their potential effects on the Company including matters related to the Company's operations, pending contracts and future revenues, financial performance, profitability, ability to execute on its increased production and installation schedules for planned capital expenditures, and the size of forecasted deposits. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties. In addition, other factors that could cause actual results to differ materially are described in the Company's most recent filings, including Form 10-K, Form 10-Q, and Form 8-K with the Securities and Exchange Commission.

Any statement that expresses or involves discussions or descriptions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance, often, but not always using words or phrases such as “believes”, “expects” or “does not expect”, “is expected”, “outlook”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “forecast”, “project”, “pro forma”, or “intends”, or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken, occur or be achieved, are not statements of historical fact and may be forward-looking statements. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak or describe only as of the date they are made and are subject to assumptions and uncertainties. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation, risks related to:

· The Company’s properties being in the exploration stage;

· Macroeconomic factors;

· Continued operational losses;

· The mineral operations being subject to government regulation;

· The Company’s ability to obtain additional capital to develop the Company’s resources, if any;

· Concentration of customers;

· Increase in energy costs;

· Mineral exploration and development activities;

· Mineral estimates;

· The Company’s insurance coverage for operating risks;

· The fluctuation of prices for antimony and precious metals, such as gold and silver;

· The competitive industry of mineral exploration;

· The title and rights in the Company’s mineral properties;

· Environmental hazards;

· The possible dilution of the Company’s common stock from additional financing activities;

· Metallurgical and other processing problems;

· Unexpected geological formations;

· Global economic and political conditions;

· Staffing in remote locations;

· Changes in product costing;

· Inflation on operational costs and profitability;

· Competitive technology positions and operating interruptions (including, but not limited to, labor disputes, leaks, fires, flooding, landslides, power outages, explosions, unscheduled downtime, transportation interruptions, war and terrorist activities);

· Global pandemics or civil unrest;

· Mexican labor and cartel issues regarding safety and organized control over our properties;

· The positions and associated outcomes of Mexican and other taxing authorities;

· The possible dilution of the Company’s common stock from additional financing activities;

· Cybersecurity and business disruptions;

· Potential conflicts of interest with the Company’s management;

· Not realizing the value of its USAMSA assets in Mexico upon sale or disposal; and,

· The Company’s common stock.

19

This list is not exhaustive of the factors that may affect the Company’s forward-looking statements. Some of the important risks and uncertainties that could affect forward-looking statements are described further under the sections titled “Risk Factors”, “Description of Business” and “Management’s Discussion and Analysis and Plan of Operation” of this Quarterly Report and in the Company’s filings, including Form 10-K, Form 10-Q, and Form 8-K, with the Securities and Exchange Commission. If one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. United States Antimony Corporation disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as required by law. The Company advises readers to carefully review the reports and documents filed from time to time with the Securities and Exchange Commission (the “SEC”), particularly the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

You should read this report with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect and from our historical results.

This report contains estimates, projections and other information concerning our industry, our business and the markets for our products. We obtained the industry, market and similar data set forth in this report from our own internal estimates and research and from industry research, publications, surveys and studies conducted by third parties, including governmental agencies. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. While we believe that the data we use from third parties is reliable, we have not separately verified this data. You are cautioned not to give undue weight to any such information, projections and estimates.

As used in this Quarterly Report, the terms “we,” “us,” “our,” “United State Antimony Corporation,”, “US Antimony,” “USAC,” and the “Company”, mean United States Antimony Corporation, unless otherwise indicated. All dollar amounts in this Quarterly Report are expressed in U.S. dollars, unless otherwise indicated.

Management’s Discussion and Analysis is intended to be read in conjunction with the Company’s consolidated financial statements and the integral notes (“Notes”) thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2023. The following statements may be forward-looking in nature and actual results may differ materially.

DESCRIPTION OF BUSINESS

History

United States Antimony Corporation was incorporated in Montana in January 1970 to mine and produce antimony products. In December 1983, the Company suspended its antimony mining operations in the U.S. but continued to produce antimony products using foreign sources of antimony ore. In April 1998, the Company formed US Antimony de Mexico, S.A. de C.V. (“USAMSA”) to smelt antimony in Mexico, and, in August 2005, the Company formed Antimonio de Mexico, S.A. de C.V. (“ADM”) to explore and develop antimony and precious metal deposits in Mexico. The Company formed Bear River Zeolite Company (“BRZ”) in 2000 for the purpose of mining and producing zeolite in Idaho. Our principal business is the production and sale of antimony, precious metals, primarily gold and silver, and zeolite products. In May 2012, our shares of common stock started trading on the NYSE MKT (now NYSE AMERICAN) under the symbol UAMY.

On March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary, operations, or assets. See Note 1 and Note 11of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report for further information. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. Accordingly, the consolidated financial statements and notes to the consolidated financial statements reflect the results of USAMSA as a discontinued operation and are excluded from continuing operations and segment results for all periods presented.

20

Although we extract minerals from the Bear River Zeolite property in Idaho that we later process and sell, we have not yet prepared a technical report summary for the Bear River Zeolite property making a determination on the property’s mineral resources or mineral reserves. However, the Company is in the process of beginning this initiative.

The Company is organized and managed by the following four segments, which represent our operating units: United States antimony segment, Mexico antimony segment, zeolite segment, and precious metals segment. See Note 11 of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report for the Mexico discontinued operations that are excluded from business segments.

United States Antimony Segment

Our United States antimony segment consists of an antimony plant in the Burns Mining District of Sanders County in Montana, which primarily produces antimony oxide, antimony metal, antimony trisulfide, and precious metals. Antimony oxide is a fine, white powder. Our antimony oxide is used in conjunction with a halogen to form a synergistic flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. Our antimony oxide is also used as a color fastener in paint and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries and ordnance. Our antimony trisulfide is used as a primer in ammunition. The precious metals processed at this plant in Montana are included in our precious metals segment.

We closed our antimony mine and mill in Montana in December 1983 because antimony ore could be purchased more economically from foreign sources. Our mine and mill are approximately 1 mile from our current antimony smelter plant in Montana. We hold one patented claim at the mine. The environmental permitting process currently precludes mining at our mine in Montana.

As a result of the mine and mill closure, we have relied on sources outside the U.S. for antimony ore since 1983, and there are risks of interruption in procurement from these sources and volatile changes in world market prices for these materials that are not controllable by us. We anticipate continuing to receive antimony ore primarily from a supplier in Canada but will continue to explore Mexico and Central America for suppliers of antimony ore, assuming economics are profitable. The acquisition of antimony ore is technically complex and a function of the country’s laws and regulations. Our purchasing consequently requires flexibility regarding supply agreements and is tailored accordingly to specific suppliers.

We estimate (but have not independently confirmed) that our present share of the domestic and international markets for antimony oxide products is approximately 4% and less than 1%, respectively. We are the only significant U.S. producer of antimony products. We believe we are competitive both domestically and world-wide due to the following:

· We are the only U.S. domestic producer of antimony products.

· We can ship on short notice to domestic customers.

· We have a reputation for quality products delivered on a timely basis.

· We have the only operating, permitted antimony smelter in the U.S.

21

Mexico Antimony Segment

The Company has two subsidiaries in Mexico, USAMSA and ADM. On March 11, 2024, we shut down the operational activities of USAMSA, which primarily includes the following two antimony and precious metals processing plants in Mexico: (1) the Madero smelter in Coahuila, and (2) the Puerto Blanco flotation mill, oxide circuit, and cyanide leach circuit in Guanajuato. The Company intends to sell its USAMSA subsidiary, operations, or assets over the next year and has initiated an active search for buyers or leasing opportunities of its operations and/or existing assets.

We will maintain our existing Los Juarez mining claims and concessions in Cadereyta de Montes Queretaro, Mexico, which are included in our ADM subsidiary. There are presently no active operations at Los Juarez.

Zeolite Segment

Our zeolite segment consists of a mine and mill in Preston, Idaho, Bear River Zeolite, Inc. (“BRZ”), which produces zeolite. Our zeolite is used for various purposes including soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications.

BRZ has a lease with Zeolite, LLC that entitles BRZ to surface mine and process zeolite on property in Preston, Idaho, in exchange for a royalty payment. The annual royalty payment is the greater of: (1) the minimum annual royalty of $60,000, adjusted annually for the Consumer Price Index for all Urban Consumers, or (2) $11.00 per ton for the first ten thousand tons, $9.90 per ton for tons in excess of ten thousand up to twenty thousand, and $8.80 per ton for tons in excess of twenty thousand. This Zeolite LLC lease also requires BRZ to pay $10,000 to the lessor on March 1 of each year during the term of the lease, which ends March 1, 2025. BRZ also pays two other royalties on the sale of zeolite products. On a combined basis, BRZ pays royalties ranging from 8% to 13% on the sale of zeolite products. In addition, BRZ can surface mine and process zeolite on property owned by the U.S. Bureau of Land Management that is adjacent to the Company’s Preston, Idaho property after obtaining required permits.

“Zeolite” refers to a group of industrial minerals that consist of hydrated aluminosilicates that hold cations such as calcium, sodium, ammonium, various heavy metals, and potassium in their crystal lattice. Water is loosely held in cavities in the lattice. BRZ zeolite is regarded as one of the best zeolites in the world due to its high cation exchange capacity (CEC) of approximately 180-220 meq/100 gr. (which predicts plant nutrient availability and retention in soil), its hardness and high clinoptilolite content (which is an effective barrier to prevent problematic radionuclide movement), its absence of clay minerals, and its low sodium content. Our zeolite is used in:

☐	Soil Amendment and Fertilizer. Zeolite has been successfully used to fertilize golf courses, sports fields, parks and common areas, and high value agricultural crops.
☐	Water Filtration. Zeolite is used for particulate, heavy metal and ammonium removal in swimming pools, municipal water systems, fisheries, fish farms, and aquariums.
☐	Sewage Treatment. Zeolite is used in sewage treatment plants to remove nitrogen and as a carrier for microorganisms.

22

☐	Nuclear Waste and Other Environmental Cleanup. Zeolite has shown a strong ability to selectively remove strontium, cesium, radium, uranium, and various other radioactive isotopes from solution. Zeolite can also be used for the cleanup of soluble metals such as mercury, chromium, copper, lead, zinc, arsenic, molybdenum, nickel, cobalt, antimony, calcium, silver and uranium.
☐	Odor Control. A major cause of odor around cattle, hog, and poultry feed lots is the generation of the ammonium in urea and manure. The ability of zeolite to absorb ammonium prevents the formation of ammonia gas, which disperses the odor.

☐	Gas Separation. Zeolite has been used for some time to separate gases, to re-oxygenate downstream water from sewage plants, smelters, pulp and paper plants, and fishponds and tanks, and to remove carbon dioxide, sulfur dioxide and hydrogen sulfide from methane generators as organic waste, sanitary landfills, municipal sewage systems, animal waste treatment facilities, and is excellent in pressure swing apparatuses.
☐	Animal Nutrition. According to third-party research, feeding up to 2% zeolite increases growth rates, decreases conversion rates, and prevents scours.
☐	Miscellaneous Uses. Other uses include catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, floor cleaner, traction control, ammonia removal from mining waste, and carriers for insecticides, pesticides and herbicides.

Precious Metals Segment

Our precious metals segment consists of a precious metals recovery plant that is operated in conjunction with the antimony processing plant in Montana. Precious metals are recovered in the leach circuit and settling pond after the ore goes through the crushing and flotation cycles. When precious metals are contained in antimony source, the metallurgical techniques employed for the recovery of antimony are altered to also recover the precious metals.  The principal source of antimony concentrates bearing precious metals came from our Canadian supplier, who also purchases precious metals from the Company. 

SELECTED FINANCIAL DATA.

Results of Operations of Continuing Operations:

Consolidated Statements of Operations Information of Continuing Operations:	For the three months ended
	March 31, 2024			March 31, 2023
Revenues	$	2,831,390		$	2,210,844
Costs of revenues		2,008,486			1,816,001
Gross profit		822,904			394,843
Total operating expenses		891,650			314,967
Income (loss) from continuing operations		(68,746	)		79,876
Total other income		154,847			213,505
Income tax expense		-			-
Net income from continuing operations	$	86,101		$	293,381

23

Balance Sheet Information of Continuing Operations:

Consolidated Balance Sheet Information, Excluding Discontinued Operations:
	March 31, 2024			December 31, 2023
Working capital		13,043,414			12,963,081
Total assets	$	21,574,403		$	21,547,455
Accumulated deficit	$	(39,741,387	)	$	(39,418,619	)
Total stockholders’ equity	$	25,404,125		$	25,520,968

Operational and Financial Performance of Continuing Operations by Segment:

Antimony

Financial and operational performance of antimony for the three months ended March 31, 2024 and 2023 was as follows:

	For the three months ended
Antimony - Combined USA and Mexico	March 31, 2024		March 31, 2023		$ Change			% Change
Revenue	$	2,228,385	$	1,612,639	$	615,746			38.2	%
Gross profit	$	1,121,591	$	255,158	$	866,433			339.6	%
Pounds of antimony sold		522,173		343,044		179,129			52.2	%
Average sales price per pound	$	4.27	$	4.70	$	(0.43	)		(9.2	)%
Average cost per pound	$	2.12	$	3.96	$	(1.84	)		(46.4	)%
Average gross profit per pound	$	2.15	$	0.74	$	1.40			188.8	%

Antimony revenue increased $615,746, or 38%, during the three months ended March 31, 2024, compared to the three months ended March 31, 2023, primarily due to the increased pounds of antimony sold mainly from increased demand for antimony oxide and metal. A portion of the increased demand for antimony metal is related to the processing of customer-owned antimony ore. The sales price per pound related to the processing of customer-owned antimony ore is lower than the sales price per pound for our other antimony products. Therefore, the increased revenue from the processing of customer-owned antimony ore for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, was the primary reason for the decrease in our overall average sales price per pound.

Gross profit increased $866,433 for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, primarily due to the increased pounds of antimony sold from increased demand for antimony oxide and metal. The improved results related to average gross profit per pound in both periods presented relates to discontinuing our Mexico antimony operations, the results of which are not included in the continuing operations information presented but rather included in discontinued operations in Note 11of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report.

24

Zeolite

Financial and operational performance of zeolite for the three months ended March 31, 2024 and 2023 was as follows:

	For the three months ended
Zeolite	March 31, 2024			March 31, 2023		$ Change			% Change
Revenue	$	603,005		$	482,093	$	120,912			25.1	%
Gross profit (loss)	$	(292,833	)	$	29,427	$	(322,260	)		(1095.1	)%
Tons of zeolite sold		2,273			2,063		210			10.2	%
Average sales price per ton	$	265		$	234	$	32			13.5	%
Average cost per ton	$	394		$	219	$	175			79.6	%
Average gross profit (loss) per ton	$	(129	)	$	14	$	(143	)		(1003.2	)%

Zeolite revenue increased $120,912, or 25%, during the three months ended March 31, 2024, compared to the three months ended March 31, 2023, primarily due to:

· The increased tons of zeolite sold mainly from increased demand and our ability to meet customer orders in a more timely fashion, and

· The increased average sales price per ton mainly from a price increase that was effective towards the end of 2023.

Gross profit decreased by $322,260 in the three months end March 31, 2024, compared to the three months ended March 31, 2023, primarily due to increased maintenance costs and inefficient facility and labor-related costs in repairing older equipment and production downtime issues in the first quarter of 2024 versus 2023.

Precious Metals

Financial and operational performance of precious metals for the three months ended March 31, 2024 and 2023 was as follows:

	For the three months ended
Precious metals	March 31, 2024			March 31, 2023		$ Change			% Change
Revenue	$	-		$	116,112	$	(116,112	)		(100.0	)%
Gross profit (loss)	$	(5,854	)	$	110,258	$	(116,112	)		(105.3	)%
Ounces sold - gold		-			11.82		(11.82	)		(100.0	)%
Ounces sold - silver		-			7,337		(7,337	)		(100.0	)%

Earnings before Interest, Tax, Depreciation and Amortization (“EBITDA”)

In addition to our results determined in accordance with GAAP, we believe Earnings Before Interest, Tax, Depreciation and Amortization (“EBITDA”), a non-GAAP financial measure, is a useful measure of our operating performance because it eliminates non-cash expenses that do not reflect our underlying business performance. We use this measure to facilitate a comparison of our operating performance on a consistent basis from period to period and to analyze the factors and trends affecting our business.

EBITDA is intended as a supplemental measure of our performance that is neither required by, nor presented in accordance with, GAAP. We believe that the use of EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with those of comparable companies, which may present similar non-GAAP financial measures to investors. EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP.

Our EBITDA was $192,899 for the three months ended March 31, 2024, compared to EBITDA of $366,312 for the three months ended March 31, 2023.

25

EBIDTA of continuing operations by segment for the three months ended March 31, 2024 and 2023 was as follows:

	For the three months ended
Antimony – Combined USA and Mexico	March 31, 2024			March 31, 2023			$ Change			% Change
Revenue	$	2,228,385		$	1,612,639		$	615,746			38.2	%
Cost of sales		(1,106,794	)		(1,357,481	)		250,687			(18.5	)%
Gross profit (loss)		1,121,591			255,158			866,433			339.6	%
Total operating expenses		(752,982	)		(220,935	)		(532,047	)		240.8	%
Income (loss) from operations		368,609			34,223			334,386			977.1	%
Total other income (expense)		157,164			213,599			(56,435	)		(26.4	)%
Income tax expense		-			-			-
Net income (loss) - antimony		525,773			247,822			277,951			112.2	%
Interest expense		-			1,298			(1,298	)		(100.0	)%
Income tax expense		-			-			-
Depreciation and amortization		17,965			12,304			5,661			46.0	%
EBITDA - antimony	$	543,738		$	261,424		$	282,314			108.0	%

	For the three months ended
Zeolite	March 31, 2024			March 31, 2023			$ Change			% Change
Revenue	$	603,005		$	482,093		$	120,912			25.1	%
Cost of sales		(895,838	)		(452,666	)		(443,172	)		97.9	%
Gross profit (loss)		(292,833	)		29,427			(322,260	)		(1095.1	)%
Total operating expenses		(138,668	)		(94,032	)		(44,636	)		47.5	%
Income (loss) from operations		(431,501	)		(64,605	)		(366,896	)		567.9	%
Total other income (expense)		(2,317	)		(94	)		(2,223	)		2364.9	%
Income tax expense		-			-			-			0.0	%
Net income (loss) - zeolite		(433,818	)		(64,699	)		(369,119	)		570.5	%
Interest expense		651			2,301			(1,650	)		(71.7	)%
Income tax expense		-			-			-
Depreciation and amortization		82,328			51,174			31,154			60.9	%
EBITDA - zeolite	$	(350,839	)	$	(11,224	)	$	(339,615	)		3025.8	%

26

	For the three months ended
Precious Metals	March 31, 2024			March 31, 2023			$ Change			% Change
Revenue	$	-		$	116,112		$	(116,112	)		(100.0	)%
Cost of sales		(5,854	)		(5,854	)		-			0.0	%
Gross profit (loss)		(5,854	)		110,258			(116,112	)		(105.3	)%
Total operating expenses		-			-			-			0.0	%
Income (loss) from operations		(5,854	)		110,258			(116,112	)		(105.3	)%
Total other income (expense)		-			-			-			n/a
Net income (loss) - precious metals		(5,854	)		110,258			(116,112	)		(105.3	)%
Interest expense		-			-			-			n/a
Depreciation and amortization		5,854			5,854			-			0.0	%
EBITDA - precious metals	$	-		$	116,112		$	(116,112	)		(100.0	)%

	For the three months ended
Consolidated	March 31, 2024			March 31, 2023			$ Change			% Change
Revenue	$	2,831,390		$	2,210,844		$	620,546			28.1	%
Cost of sales		(2,008,486	)		(1,816,001	)		(192,485	)		10.6	%
Gross profit (loss)		822,904			394,843			428,061			108.4	%
Total operating expenses		(891,650	)		(314,967	)		(576,683	)		183.1	%
Income (loss) from operations		(68,746	)		79,876			(148,622	)		(186.1	)%
Total other income (expense)		154,847			213,505			(58,658	)		(27.5	)%
Income tax expense		-			-			-
Net income (loss) - consolidated		86,101			293,381			(207,280	)		(70.7	)%
Interest expense		651			3,599			(2,948	)		(81.9	)%
Income tax expense		-			-			-
Depreciation and amortization		106,147			69,332			36,815			53.1	%
EBITDA - consolidated	$	192,899		$	366,312		$	(173,413	)		(47.3	)%

27

Capital Resources and Liquidity:

WORKING CAPITAL OF CONTINUING OPERATIONS	March 31, 2024			December 31, 2023
Current assets	$	13,791,433		$	13,709,251
Current liabilities		(748,019	)		(746,170	)
Working capital	$	13,043,414		$	12,963,081

	For the three months ended
CASH FLOWS OF CONTINUING OPERATIONS	March 31, 2024			March 31, 2023
Net cash provided by operating activities	$	350,225		$	(1,068,974	)
Net cash used by investing activities		(2,031	)		(501,202	)
Net cash used by financing activities		(21,273	)		(810,752	)
Net cash provided (used) by continuing operations	$	326,921		$	(2,380,928	)

Cash flow provided by operating activities improved by $1,419,199 for the three months ended March 31, 2024 compared to the three months ended March 31, 2023 primarily due to good working capital management with better collections on receivables, better inventory management, and maintaining a lower amount due on royalties.

Cash flow used by investing activities improved by $499,171 for the three months ended March 31, 2024 compared to the three months ended March 31, 2023 primarily due to less fixed asset purchases.

Cash flow used by financing activities improved by $789,479 for the three months ended March 31, 2024 compared to the three months ended March 31, 2023 primarily due to the payment of a dividend of $787,730 on January 25, 2023 to the holders of 1,692,672 shares of Series D Preferred stock.

Our mission is to service our employees, customers, and vendors well and grow our business profitably both organically and through strategic acquisitions to increase shareholder value. The Company is focused on generating positive cash flow to fund its mission. One method of improving positive cash flow has been through our review of each segment’s operations and financial results to make informed decisions that benefit the Company overall. An example of the results of our review relates to USAMSA. Our USAMSA entity has generated cumulative losses since inception. Therefore, we shut down the operations of our USAMSA entity on March 11, 2024 and intend to sell this entity, operations, or assets over the next year. We have initiated an active search for buyers of USAMSA’s operations and/or existing assets. Such sale would provide additional cash.

Another method of generating cash is through the sale or issuance of common stock, warrants, debt, and other investment vehicles, which the Company has been successful at executing in the past. However, our ability to access capital or raise funds when needed is not assured and, if capital is not available when, and in the amounts and terms needed, or if capital is not available at all, the Company could be required to significantly curtail its operations, modify existing strategic plans, and/or dispose of certain operations or assets, which could materially harm our business, prospects, financial condition, and operating results.

We may use cash to acquire businesses. The nature of these investments and transactions, however, makes it difficult to predict the amount and timing of such cash requirements.

As of March 31, 2024, the Company had cash and cash equivalents of $11,941,298. We intend to fund our cash requirements with our cash and cash equivalents, cash generated from our operations, and capital raised from various investment vehicles and believe cash from these sources are sufficient to cover our requirements for the next 12 months.

28

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures

At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company’s management, including the Co-Principal Executive Officers (“PEO”) and Principal Financial Officer (“PFO”), of the effectiveness of the design and operations of the Company’s disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the PEO and the PFO have concluded that our disclosure controls and procedures were not effective in ensuring that: (i) information required to be disclosed by the Company in reports that it files or submits to the SEC under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in applicable rules and forms, and (ii) material information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for accurate and timely decisions regarding required disclosure.

Management of the Company believes that these material weaknesses are due to the small size of the Company’s accounting staff. The small size of the Company’s accounting staff may prevent adequate controls in the future, such as segregation of duties, due to the cost/benefit of such remediation. To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external accounting and legal professionals. As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.

Changes in Internal Control over Financial Reporting

There have been no changes during the quarter ended March 31, 2024 in the Company’s internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.

29

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

United States Antimony Corporation is not a party to any material legal proceedings. No director, officer or affiliate of United States Antimony Corporation and no owner of record or beneficial owner of more than 5% of the Company’s securities or any associate of any such director, officer or security holder is a party adverse to United States Antimony Corporation or has a material interest adverse to United States Antimony Corporation in reference to pending litigation.

Historically, from time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At March 31, 2024 and December 31, 2023, the Company had no accrued liabilities relating to such assessments. However, during the first quarter of 2024, Bear River Zeolite Company (“BRZ”), a wholly owned subsidiary of the Company, received four significant and substantial citations from MSHA, all of which have been rectified by BRZ prior to the filing of this Quarterly Report.

ITEM 1A. RISK FACTORS.

There have been no material changes from the risk factors previously disclosed in the Company’s Form 10-K for the year ended December 31, 2023, which was filed with the SEC on April 12, 2024.

ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES.

On January 25, 2023, the holders of 1,692,672 shares of Series D Preferred stock converted the preferred shares and the Company issued 1,692,672 shares of common stock. The Company also paid the holders $787,730 for dividends payable as declared on November 28, 2022.

Per our 2023 Equity Incentive Plan, which was approved by the Company’s shareholders, the Company’s Board of Directors granted to an employee on January 29, 2024 100,000 RSUs, one-third of which vest each year beginning each anniversary subsequent to the grant date, and 200,000 stock options with performance-based vesting conditions and a 10-year term. The Company’s Board of Directors also granted 2,375,000 RSUs and 3,400,000 stock options to employees and non-employee directors on March 1, 2024 with the RSUs vesting one-third each year beginning on the grant date, 2,500,000 stock options vesting one-third each year beginning each anniversary subsequent to the grant date, and 900,000 stock options with performance-based vesting conditions and a 3-year term. One-third of RSUs granted on March 1, 2024, which equates to 791,667 shares of the Company’s common stock, vested during the three months ended March 31, 2024.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCOSURES.

The information concerning mine safety violations or other regulatory matters required by Section 1503 (a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 to this report.

ITEM 5. OTHER INFORMATION.

None.

30

ITEM 6. EXHIBITS.

Exhibit No.	Description
3.1	Second Restated Articles of Incorporation (incorporated by reference as Exhibit 3.1 to the Company’s current Report on Form 8-K filed with the SEC on January 15, 2021).
3.2	Second Restated Amended and Restated Bylaws (incorporated by reference to Exhibit 3.02 to the Company’s Current Report on Form 8-K filed with the SEC on December 20, 2012).
31.1a *	Rule 15d-14(a) Certification by Co-Principal Executive Officer.
31.1b *	Rule 15d-14(a) Certification by Co-Principal Executive Officer.
31.2 *	Rule 15d-14(a) Certification by Principal Financial Officer.
32.1 *	Section 1350 Certification of Co-Principal Executive Officers and Principal Financial Officer.
95 *	Mine Safety Disclosure.
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  _____________________

* Filed herewith.

31

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UNITED STATES ANTIMONY CORPORATION
Date: May 15, 2024	By:	/s/ Gary C. Evans
		Gary C. Evans
		Co-CEO and Chairman of the Board (co-principal executive officer)
Date: May 15, 2024	By:	/s/ Lloyd Joseph Bardswich
		Lloyd Joseph Bardswich
		Co-CEO and Director (co-principal executive officer)
Date: May 15, 2024	By:	/s/ Richard R. Isaak
		Richard R. Isaak
		SVP, Chief Financial Officer (principal financial officer)

32

EX-31.1A

EXHIBIT 31.1A

Certification

I, Gary C. Evans, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of United States Antimony Corporation for the quarter ended March 31, 2024;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 15, 2024

/s/ Gary C. Evans

Gary C. Evans

Co-CEO and Chairman of the Board

EX-31.1B

EXHIBIT 31.1B

Certification

I, Lloyd Joseph Bardswich, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of United States Antimony Corporation for the quarter ended March 31, 2024;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 15, 2024

/s/ Lloyd Joseph Bardswich

Lloyd Joseph Bardswich

Co-CEO and Director

EX-31.2

EXHIBIT 31.2

Certification

I, Richard R. Isaak, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of United States Antimony Corporation for the quarter ended March 31, 2024;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 15, 2024

/s/ Richard R. Isaak

Richard R. Isaak

SVP, Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of United States Antimony Corporation (the “Company”) on Form 10‑Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission (the “Report”), Gary C. Evans, Co-Chief Executive Officer and Chairman of the Board of the Company, Lloyd Joseph Bardswich, Co-Chief Executive Officer and Director of the Company, and Richard R. Isaak, SVP and Chief Financial Officer of the Company, each certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 15, 2024

/s/ Gary C. Evans

Gary C. Evans

Co-Chief Executive Officer and Chairman of the Board

Date: May 15, 2024

/s/ Lloyd Joseph Bardswich

Lloyd Joseph Bardswich

Co-Chief Executive Officer and Director

Date: May 15, 2024

/s/ Richard R. Isaak

Richard R. Isaak

SVP, Chief Financial Officer

EX-95

EXHIBIT 95

MINE SAFETY DISCLOSURE

Pursuant to Section 1503(a) of the recently enacted Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, issued under the Federal Mine Safety and Health Act of 1977 (the “Mine Act”) by the Mine Safety and Health Administration (the “MSHA”), as well as related assessments and legal actions, and mining-related fatalities.

The following table provides information for the quarter ended March 31, 2024:

Mine	§104 Significant and Substantial Citations (1)	§104(b) Orders (2)	§104(d) Citations and Orders (3)	§110(b)(2) Violations (4)	§107(a) Orders (5)	Proposed Assessments from MSHA (In dollars $)	Mining Related Fatalities	§104(e) Notice (yes/no) (6)	Pending Legal Action before Federal Mine Safety and Health Review Commission (yes/no)
Bear River Zeolite	4	0	0	0	0	$0	0	No	No

(1)	The total number of violations received from MSHA under §104 of the Mine Act, which includes citations for health or safety standards that could significantly and substantially contribute to a serious injury if left unabated.
(2)	The total number of orders issued by MSHA under §104(b) of the Mine Act, which represents a failure to abate a citation under §104(a) within the period of time prescribed by MSHA.
(3)	The total number of citations and orders issued by MSHA under §104(d) of the Mine Act for unwarrantable failure to comply with mandatory health or safety standards.
(4)	The total number of flagrant violations issued by MSHA under §110(b)(2) of the Mine Act.
(5)	The total number of orders issued by MSHA under §107(a) of the Mine Act for situations in which MSHA determined an imminent danger existed.
(6)	A written notice from the MSHA regarding a pattern of violations, or a potential to have such pattern under §104(e) of the Mine Act.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 15, 2024
Cover [Abstract]
Entity Registrant Name	UNITED STATES ANTIMONY CORPORATION
Entity Central Index Key	0000101538
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		108,438,984
Entity File Number	001-08675
Entity Incorporation State Country Code	MT
Entity Tax Identification Number	81-0305822
Entity Address Address Line 1	P.O. Box 643
Entity Address City Or Town	Thompson Falls
Entity Address State Or Province	MT
Entity Address Postal Zip Code	59873
City Area Code	406
Local Phone Number	827-3523
Security 12b Title	Common Stock, $0.01 par value
Trading Symbol	UAMY
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

XML

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 11,941,298	$ 11,899,574
Certificates of deposit	22,216	72,898
Accounts receivable, net	1,057,742	625,256
Inventories, net	653,010	1,019,154
Prepaid expenses and other current assets	117,167	92,369
Current assets held for sale (Note 11)	215,110	366,955
Total current assets	14,006,543	14,076,206
Properties, plants and equipment, net	7,709,812	7,765,045
Restricted cash for reclamation bonds	55,060	55,061
Non-current assets held for sale (Note 11)	6,215,574	6,180,585
Other assets	18,098	18,098
Total assets	28,005,087	28,094,995
CURRENT LIABILITIES
Accounts payable	403,441	330,147
Accrued liabilities	117,822	109,341
Accrued liabilities - directors	167,059	124,810
Royalties payable	52,527	153,429
Long-term debt, current portion	7,170	28,443
Current liabilities held for sale (Note 11)	158,103	151,288
Total current liabilities	906,122	897,458
Stock payable to directors	38,542	38,542
Asset retirement obligations	1,119,832	1,101,561
Non-current liabilities held for sale (Note 11)	536,466	536,466
Total liabilities	2,600,962	2,574,027
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Common stock, $0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares issued and outstanding, respectively	1,084,389	1,076,472
Additional paid-in capital	64,051,844	63,853,836
Accumulated deficit	(39,741,387)	(39,418,619)
Total stockholders' equity	25,404,125	25,520,968
Total liabilities and stockholders' equity	28,005,087	28,094,995
Series A Preferred Stock [Member]
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Preferred Stock Value	0	0
Series D Preferred Stock [Member]
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Preferred Stock Value	0	0
Series C Preferred Stock [Member]
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Preferred Stock Value	1,779	1,779
Series B Preferred Stock [Member]
Preferred stock $0.01 par value, 10,000,000 shares authorized:
Preferred Stock Value	$ 7,500	$ 7,500

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized shares	150,000,000	150,000,000
Common stock, issued shares	108,438,984	107,647,317
Common stock, outstanding shares	108,438,984	107,647,317
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Series A Preferred Stock [Member]
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Series D Preferred Stock [Member]
Preferred stock, issued shares	1,692,672	0
Preferred stock, outstanding shares	1,692,672	0
Preferred stock liquidation preference	$ 5,019,410	$ 0
Series C Preferred Stock [Member]
Preferred stock, issued shares	177,904	177,904
Preferred stock, outstanding shares	177,904	177,904
Preferred stock liquidation preference	$ 97,847	$ 97,847
Series B Preferred Stock [Member]
Preferred stock, issued shares	750,000	750,000
Preferred stock, outstanding shares	750,000	750,000
Preferred stock liquidation preference	$ 969,375	$ 967,500

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
REVENUES	$ 2,831,390	$ 2,210,844
COST OF REVENUES	2,008,486	1,816,001
GROSS PROFIT	822,904	394,843
OPERATING EXPENSES:
General and administrative	455,394	141,271
Salaries and benefits	241,605	127,692
Professional fees	177,157	46,004
Loss on disposal of property, plant and equipment	17,494	0
TOTAL OPERATING EXPENSES	891,650	314,967
INCOME (LOSS) FROM OPERATIONS	(68,746)	79,876
OTHER INCOME (EXPENSE):
Interest and investment income	150,851	122,372
Trademark and licensing income	6,368	7,525
Other miscellaneous income (expense)	(2,372)	83,608
TOTAL OTHER INCOME	154,847	213,505
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	86,101	293,381
Income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	86,101	293,381
Discontinued operations:
Loss from discontinued operations before income taxes	(408,869)	(1,100,365)
Income tax expense	0	0
Loss from discontinued operations (Note 11)	(408,869)	(1,100,365)
Net loss	(322,768)	(806,984)
Preferred dividends	(1,875)	(1,875)
Net loss available to common stockholders	$ (324,643)	$ (808,859)
Basic and diluted earnings per common share:
Loss from discontinued operations	$ 0	$ 0
Income from continuing operation	0	(0.01)
Net loss	0	(0.01)
Weighted average shares outstanding:
Basic	107,908,306	107,260,472
Diluted	$ 107,908,306	$ 107,260,472

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)	Total	Preferred Stock	Common Stock	Shares to be returned to treasury	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2022		2,620,576	106,373,341
Balance, amount at Dec. 31, 2022	$ 31,869,255	$ 26,205	$ 1,063,732	$ (202,980)	$ 64,052,630	$ (33,070,332)
Conversion of Preferred Series D to common stock, shares		1,692,672	1,692,672
Conversion of Preferred Series D to common stock, amount	0	$ (16,926)	$ 16,927	0	(1)	0
Common stock buyback and retirement, shares			418,696
Common stock buyback and retirement, amount	0	0	$ (4,187)	202,980	(198,793)	0
Net loss	(806,984)	$ 0	$ 0	0	0	(806,984)
Share-based compensation, shares			791,667
Balance, shares at Mar. 31, 2023		927,904	107,647,317
Balance, amount at Mar. 31, 2023	31,062,271	$ 9,279	$ 1,076,472	0	63,853,836	(33,877,316)
Balance, shares at Dec. 31, 2023		927,904	107,647,317
Balance, amount at Dec. 31, 2023	25,520,968	$ 9,279	$ 1,076,472	0	63,853,836	(39,418,619)
Net loss	(322,768)	0	0	0	0	(322,768)
Share-based compensation, amount	205,925	0	7,917	0	198,008	0
Balance, amount at Mar. 31, 2024	$ 25,404,125	$ 9,279	$ 1,084,389	$ 0	$ 64,051,844	$ (39,741,387)
Balance,shares at Mar. 31, 2024		927,904	108,438,984

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net income from continuing operations	$ 86,101	$ 293,381
Depreciation and amortization	106,147	69,332
Accretion of asset retirement obligation	18,271	375
Loss on disposal of property, plant, and equipment	17,494	0
Write down of inventory to net realizable value	80,143	0
Share-based compensation	205,925	0
Other non-cash items	(15,695)	2,041
Accounts receivable, net	(432,486)	(919,819)
Inventories, net	286,001	(76,504)
Prepaid expenses and other current assets	(24,798)	(141,852)
Accounts payable	73,294	158,942
Accrued liabilities	8,481	(55,425)
Accrued liabilities - directors	42,249	19,746
Royalties payable	(100,902)	(419,191)
Net cash provided (used) by operating activities of continuing operations	350,225	(1,068,974)
Proceeds from redemption of certificates of deposit	50,682	0
Purchases of properties, plant, and equipment	(52,713)	(501,202)
Net cash used by investing activities of continuing operations	(2,031)	(501,202)
CASH FLOWS FROM FINANCING ACTIVITIES OF CONTINUING OPERATIONS:
Payments on dividends payable	0	(787,730)
Principal payments on long-term debt	(21,273)	(23,022)
Net cash used by financing activities of continuing operations	(21,273)	(810,752)
Net cash flows provided (used) by continuing operations	326,921	(2,380,928)
Net cash used by operating activities	(285,198)	(1,204,818)
Net cash used by investing activities	0	(113,568)
Net cash flows used by discontinued operations	(285,198)	(1,318,386)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	41,723	(3,699,314)
|CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD	11,954,635	19,117,666
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	11,996,358	$ 15,418,352
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Common stock buyback and retirement		202,980
Conversion of Preferred Series D to Common Stock	$ 0	$ 16,926

XML

NATURE OF OPERATIONS

3 Months Ended

Mar. 31, 2024

NATURE OF OPERATIONS

NATURE OF OPERATIONS

 NOTE 1 - NATURE OF OPERATIONS

United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover certain amounts of precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.

Developments in the Current Period - Discontinued Operations

The Company has two subsidiaries in Mexico, US Antimony de Mexico, S.A. de C.V. (“USAMSA”) and Antimonio de Mexico, S.A. de C.V. (“ADM”). On March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary, operations, or assets. The USAMSA subsidiary primarily includes the Company’s Madero antimony and precious metals plant in Parras de la Fuente Coahuila, Mexico and its Puerto Blanco antimony and precious metals plant in San Luis de la Paz Guanajuato, Mexico. The Company intends to sell its USAMSA subsidiary, operations, or assets over the next year and has initiated an active search for buyers of its operations and/or existing assets. While the Company will maintain its existing Los Juarez mining claims and concessions in Mexico, which are included in our ADM subsidiary, there are presently no active operations at Los Juarez. See Note 11 for further information.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2024

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of March 31, 2024, and its results of operations and cash flows for the three months ended March 31, 2024 and 2023. The Condensed Consolidated Balance Sheet as of December 31, 2023, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on April 12, 2024.

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements.

Reclassifications

Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. 

Discontinued Operations

Disposal groups that meet the discontinued operations criteria by the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-20-45 are classified as discontinued operations and are excluded from continuing operations and segment results for all periods presented.

Share-Based Compensation

The Company’s share-based awards consist of restricted stock units (“RSUs”) and stock options granted to employees and non-employee directors.

RSUs are stock awards entitling the award recipient to a specified number of shares of the Company’s common stock as the award vests. Each of our RSU grants include a time-based vesting condition, which is the only vesting condition related to the RSU grants. The Company calculates the fair value of RSUs on the grant date using the closing market price of the Company’s common stock on the grant date. The Company expenses the grant date fair value of RSUs ratably over the requisite service period, other than RSUs that vest on the grant date, the grant date fair value of which is expensed on the grant date. The Company recognizes forfeitures as they occur.

Stock options grant award recipients the option to purchase a specified number of shares of the Company’s common stock at an exercise price per share specified in the grant agreement as the stock options vest. Stock option grants include either a time-based vesting condition or performance-based vesting conditions with a specified term to meet the performance condition. The Company calculates the fair value of stock options on the grant date using the Black-Scholes option-pricing model, which requires the Company to make estimates and assumptions, such as expected volatility, expected term, and risk-free interest rate. For time-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably over the requisite service period. For performance-based vesting stock option grants, the Company expenses the grant date fair value of the award based on the probability and timing of achieving the performance criteria. The Company recognizes forfeitures as they occur.

The expense related to employee and non-employee director share-based awards is recorded in “Salaries and benefits” and “General and administrative,” respectively, in the Condensed Consolidated Statements of Operations.

Recent Accounting Pronouncements

Management does not believe that any recently issued but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, amending reportable segment disclosure requirements to include disclosure of incremental segment information on an annual and interim basis. Among the disclosure enhancements are new disclosures regarding significant segment expenses that are regularly provided to the chief operating decision-maker and included within each reported measure of segment profit or loss, as well as other segment items bridging segment revenue to each reported measure of segment profit or loss. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, and are applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures. 

XML

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2024

EARNINGS PER SHARE

EARNINGS PER SHARE

NOTE 3 – EARNINGS PER SHARE

Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through convertible preferred stock, stock options, RSUs, and warrants.

At March 31, 2024 and 2023, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive were as follows:

	March 31, 2024		March 31, 2023
Warrants		12,346,215		12,346,215
RSUs		225,695		-
Total possible dilution		12,571,910		12,346,215

XML

REVENUE RECOGNITION

3 Months Ended

Mar. 31, 2024

REVENUE RECOGNITION

REVENUE RECOGNITION

NOTE 4 – REVENUE RECOGNITION

Products consist of the following:

· Antimony: includes antimony oxide, antimony metal, antimony trisulfide.

· Zeolite: includes coarse and fine zeolite crushed in various sizes.

· Precious metals: includes unrefined and refined gold and silver.

Sales of products for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024		March 31, 2023
Antimony product revenue	$	2,228,385	$	1,612,639
Zeolite product revenue		603,005		482,093
Precious metals product revenue		-		116,112
TOTAL REVENUES	$	2,831,390	$	2,210,844

Domestic and foreign revenues for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024		March 31, 2023
Domestic revenues	$	2,280,774	$	1,991,230
Foreign revenues		550,616		219,614
TOTAL REVENUES	$	2,831,390	$	2,210,844

The Company’s trade accounts receivable balance related to contracts with customers was $1,057,742 at March 31, 2024 and $625,256 at December 31, 2023, net of an allowance for doubtful accounts related to trade accounts receivables of $271,212 at March 31, 2024 and December 31, 2023. The Company’s products do not involve any warranty agreements and product returns are not typical.

XML

INVENTORIES

3 Months Ended

Mar. 31, 2024

INVENTORIES

INVENTORIES

NOTE 5– INVENTORIES

Inventories at March 31, 2024 and December 31, 2023 consisted primarily of finished antimony metal and oxide products, antimony ore and concentrates, and finished zeolite products. Inventories are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products and finished zeolite products costs include direct materials, direct labor, overhead, depreciation, and freight. Inventories at March 31, 2024 and December 31, 2023 were as follows:

	March 31, 2024		December 31, 2023
Antimony oxide inventory	$	136,245	$	252,927
Antimony metal inventory		90,631		237,429
Antimony ore and concentrates inventory		24,482		23,752
Total antimony inventory		251,358		514,108
Zeolite inventory		401,652		505,046
TOTAL INVENTORIES	$	653,010	$	1,019,154

At March 31, 2024 and December 31, 2023, inventories were valued at cost, except for the portion of inventory related to zeolite which was valued at net realizable value because costs were greater than the amount the Company expected to receive on the sale of zeolite inventory. The adjustment to inventory for net realizable value was $80,143 and $Nil for the three months ended March 31, 2024 and 2023, respectively.

Antimony oxide and metal inventory consisted of finished product held by the Company’s plants in Montana and Mexico. Antimony ore and concentrates were held primarily at its sites in Montana and Mexico. The Company’s zeolite inventory consisted primarily of saleable zeolite material at the Company’s plant located in Idaho.

XML

PROPERTIES PLANTS AND EQUIPMENT

3 Months Ended

Mar. 31, 2024

PROPERTIES PLANTS AND EQUIPMENT

PROPERTIES, PLANTS AND EQUIPMENT

NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT

The major components of the Company’s properties, plants and equipment (“PP&E”) by segment at March 31, 2024 and December 31, 2023 were as follows:

March 31, 2024	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,368,804		$	234,174		$	7,357,423
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			18,590			-			18,590
PP&E, gross	$	4,645,890		$	1,420,958		$	8,100,076		$	234,174		$	14,401,098
Accumulated depreciation		(2,675,660	)		(239,047	)		(3,597,180	)		(179,399	)		(6,691,286	)
PP&E, net	$	1,970,230		$	1,181,911		$	4,502,896		$	54,775		$	7,709,812

December 31, 2023	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,336,808		$	234,174		$	7,325,427
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			8,951			-			8,951
PP&E, gross	$	4,645,890		$	1,420,958		$	8,058,441		$	234,174		$	14,359,463
Accumulated depreciation		(2,661,719	)		(235,024	)		(3,524,130	)		(173,545	)		(6,594,418	)
PP&E, net	$	1,984,171		$	1,185,934		$	4,534,311		$	60,629		$	7,765,045

XML

DEBT

3 Months Ended

Mar. 31, 2024

DEBT

DEBT

NOTE 7 – LONG-TERM DEBT

Long-term debt at March 31, 2024 and December 31, 2023 was as follows:

	March 31, 2024			December 31, 2023
Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck	$	7,170		$	28,443
Total debt		7,170			28,443
Less current portion of debt		(7,170	)		(28,443	)
Long term portion of debt	$	-		$	-

The principal payments owed Caterpillar Financial Services of $7,170 at March 31, 2024 will be due in April 2024. 

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2024

COMMITMENTS AND CONTINGENCIES (Note 8)

COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

The Company follows U.S. GAAP guidance in determining its accruals and disclosures with respect to loss contingencies and evaluates such accruals and contingencies for each reporting period. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information available prior to issuance of the financial statements indicates that it is probable that a loss could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred.

Historically, from time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At March 31, 2024 and December 31, 2023, the Company had no accrued liabilities relating to such assessments. However, during the first quarter of 2024, Bear River Zeolite Company (“BRZ”), a wholly owned subsidiary of the Company, received four significant and substantial citations from MSHA, all of which have been rectified by BRZ prior to the filing of this quarterly report.

On a combined basis, BRZ pays royalties ranging from 8% to 13% on the sale of zeolite products. At March 31, 2024 and December 31, 2023, the Company had accrued royalties payable of $52,527 and $153,429, respectively.

XML

STOCKHOLDERS EQUITY

3 Months Ended

Mar. 31, 2024

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

On January 25, 2023, the holders of 1,692,672 shares of Series D Preferred stock converted the preferred shares and the Company issued 1,692,672 shares of common stock.  The Company also paid the holders $787,730 for dividends payable as declared on November 28, 2022. 1,590,672 shares of the 1,692,672 shares of Series D Preferred stock that were converted and $740,261 of the $787,730 of dividends paid related to the estate of John Lawrence, who was a prior President and Chairman of the Company.

On January 26, 2023, in conjunction with its share repurchase plan, the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980.

Stock option and RSU awards were granted on January 29, 2024 and March 1, 2024 in accordance with our 2023 Equity Incentive Plan, which was approved by the Company’s shareholders. No other equity grants were outstanding at March 31, 2024. The Company’s Board of Directors granted to an employee on January 29, 2024 100,000 RSUs, one-third of which vest each year beginning each anniversary subsequent to the grant date, and 200,000 stock options with performance-based vesting conditions and a 10-year term. The fair value of the RSUs granted on January 29, 2024 was $24,000 and the fair value of the stock options granted on January 29, 2024 was $48,000. The Company’s Board of Directors also granted 2,375,000 RSUs and 3,400,000 stock options to employees and non-employee directors on March 1, 2024 with the RSUs vesting one-third each year beginning on the grant date, 2,500,000 stock options vesting one-third each year beginning each anniversary subsequent to the grant date, and 900,000 stock options with performance-based vesting conditions and a 3-year term. The fair value of the RSUs granted on March 1, 2024 was $522,500 and the fair value of the stock options granted on March 1, 2024 was $544,000. One-third of the RSUs granted on March 1, 2024, which equates to 791,667 shares of the Company’s common stock, vested during the three months ended March 31, 2024. At March 31, 2024, 1,583,333 RSU’s are unvested from the March 1, 2024 grant and 100,000 RSUs are unvested from the January 29, 2024 grant. The Company expensed $205,925 and $nil during the three months ended March 31, 2024 and 2023, respectively, related to stock option and RSU grants.

The remaining unrecognized compensation expense for RSUs granted on January 29, 2024 was $22,667 at March 31, 2024, which is expected to be recognized over the next 2.83 years. The remaining unrecognized compensation expense for RSUs granted on March 1, 2024 was $333,819 at March 31, 2024, which is expected to be recognized over the next 2.92 years.

The remaining unrecognized compensation expense for stock options granted on January 29, 2024 was $47,200 at March 31, 2024, which is expected to be recognized over the next 8.33 years. These stock options had no intrinsic value at March 31, 2024. The remaining unrecognized compensation expense for stock options granted on March 1, 2024 was $528,889 at March 31, 2024, which is expected to be recognized over the next 2.92 years. The intrinsic value of these stock options at March 31, 2024 was $102,000.

The fair value of stock options granted on January 29, 2024 and March 1, 2024 and the key assumptions used in the Black-Scholes valuation model to calculate the fair value are as follows:

	Stock Options			Stock Options
	Granted On			Granted On
	January 29, 2024			March 1, 2024
Fair value per share of options granted	$	0.24		$	0.16
Options granted		200,000			3,400,000
Exercise price per share	$	0.25		$	0.22
Expected Term (in years)		10			3
Risk-free rate		4.08	%		4.32	%
Volatility		302.65	%		116.28	%

Common stock warrants

No warrants were issued, expired, or exercised during the three months ended March 31, 2024 and 2023.

The composition of the Company’s warrants outstanding at March 31, 2024 and 2023 was as follows:

Number of warrants		Exercise Price		Expiration Date	Remaining life (years)
	2,285,715	$	0.46	7/31/2025		1.33
	804,000	$	0.46	1/27/2026		1.83
	7,650,000	$	0.85	8/3/2026		2..34
	1,606,500	$	0.85	2/1/2026		1.84
	12,346,215

XML

BUSINESS SEGEMENTS

3 Months Ended

Mar. 31, 2024

BUSINESS SEGEMENTS

BUSINESS SEGEMENTS

NOTE 10 – BUSINESS SEGEMENTS

The Company is organized and managed with four business segments, which represent our operating units: United States antimony operations, Mexico antimony operations, precious metals recovery and United States zeolite operations. See Note 11 for the Mexico discontinued operations that are excluded from business segments.

Total assets by segment at March 31, 2024 and December 31, 2023 were as follows: 

Total Assets, Excluding Discontinued Operations	March 31, 2024		December 31, 2023
Antimony segment:
United States total assets	$	14,962,876	$	14,769,408
Mexico total assets		1,248,036		1,211,319
Subtotal antimony segment	$	16,210,912	$	15,980,727
Precious metals segment:
United States total assets	$	86,864	$	92,718
Mexico total assets		-		-
Subtotal precious metals segment	$	86,864	$	92,718
Zeolite segment		5,276,627		5,474,010
Total assets, excluding discontinued operations	$	21,574,403	$	21,547,455

Total capital expenditures by segment for the three months ended March 31, 2024 and 2023 were as follows: 

Capital expenditures, Excluding Discontinued Operations	For the three months ended
	March 31, 2024		March 31, 2023
Antimony segment:
United States capital expenditures	$	-	$	3,550
Mexico capital expenditures		-		-
Subtotal antimony segment	$	-	$	3,550
Precious metals segment		-		-
Zeolite segment		52,713		497,652
Total capital expenditures, excluding discontinued operations	$	52,713	$	501,202

Selected segment operational information for the three months ended March 31, 2024 and 2023 were as follows:

Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2024	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	2,228,385	$	-	$	2,228,385	$	-	$	603,005	$	2,831,390
Depreciation and amortization		13,941		4,024		17,965		5,854		82,328		106,147
Income (loss) from operations	$	394,806	($26,197)		$	368,609	($5,854)		($431,501)		(68,746)
Other income												154,847
Income tax expense												-
NET INCOME											$	86,101
Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2023	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	1,612,639	$	-	$	1,612,639	$	116,112	$	482,093	$	2,210,844
Depreciation and amortization		8,280		4,024		12,304		5,854		51,174		69,332
Income (loss) from operations	$	62,072	($27,849)		$	34,223	$	110,258	($64,605)		$	79,876
Other income												213,505
Income tax expense												-
NET INCOME											$	293,381

XML

DISCONTINUED OPERATIONS

3 Months Ended

Mar. 31, 2024

BUSINESS SEGEMENTS

DISCONTINUED OPERATIONS

NOTE 11 – DISCONTINUED OPERATIONS

As described in Note 1, on March 11, 2024, the Company shut down the operations of USAMSA and announced its plans to sell its USAMSA subsidiary, operations, or assets over the next year. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. Accordingly, the condensed consolidated financial statements and notes to the condensed consolidated financial statements reflect the results of USAMSA as a discontinued operation and are excluded from continuing operations and segment results for all periods presented.

Our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows report discontinued operations separate from continuing operations. Our Condensed Consolidated Statements of Equity combine the results of continuing and discontinued operations.

The key components of the loss from discontinued operations for the three months ended March 31, 2024 and 2023 were as follows:

	For the three months ended
	March 31, 2024			March 31, 2023
REVENUES	$	240,677		$	-
COST OF REVENUES		474,096			930,262
GROSS PROFIT LOSS		(233,419	)		(930,262	)
OPERATING EXPENSES:
General and administrative		44,892			14,323
Professional fees		35,151			38,802
Other operating expenses		88,246			108,345
TOTAL OPERATING EXPENSES		168,289			161,470
LOSS FROM OPERATIONS		(401,708	)		(1,091,732	)
OTHER EXPENSE:
Other miscellaneous expense		(7,161	)		(8,633	)
TOTAL OTHER EXPENSE		(7,161	)		(8,633	)
LOSS FROM DISCONTINUED OPERATIONS BEFORE TAX		(408,869	)		(1,100,365	)
Income tax expense		-			-
LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX	$	(408,869	)	$	(1,100,365	)

Depreciation and amortization expense of USAMSA totaled $nil and $154,909 for the three months ended March 31, 2024 and 2023, respectively.

Accretion of asset retirement obligation of USAMSA totaled $nil and $2,993 for the three months ended March 31, 2024 and 2023, respectively.

Write down of inventory to net realizable value of USAMSA totaled $43,074 and $246,792 for the three months ended March 31, 2024 and 2023, respectively.

Capital expenditures of USAMSA totaled $nil and $113,568 for the three months ended March 31, 2024 and 2023, respectively.

The carrying amounts of major classes of assets and liabilities of USAMSA included in assets and liabilities of discontinued operations were as follows:

	March 31, 2024		December 31, 2023
ASSETS
CURRENT ASSETS
Inventories, net	$	215,110	$	366,955
Total current assets, discontinued operations		215,110		366,955
Properties, plants and equipment, net		5,689,446		5,689,446
IVA receivable and other assets, net		526,128		491,139
Total assets, discontinued operations	$	6,430,684	$	6,547,540
LIABILITIES
CURRENT LIABILITIES
Accounts payable	$	137,744	$	126,788
Accrued liabilities		20,359		24,500
Total current liabilities, discontinued operations		158,103		151,288
Asset retirement obligations		536,466		536,466
Total liabilities, discontinued operations	$	694,569	$	687,754

Mexican Tax Assessment

In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The assessment was settled in 2018 with no assessment due from the Company.

In early 2019, the Company was notified that SAT re-opened its assessment of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $795,000 USD as of December 31, 2021.

Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believes the findings have no merit. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. The Company posted a guarantee of the amount in March 2020 as is required under the appeal process. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments.  In 2022, the Mexican court ruled against the Company in the above matter. The Company subsequently appealed the ruling.

As of December 31, 2023, the updated SAT assessment was approximately $22.4 million pesos, or approximately $1,320,000 USD, which includes $352,000 of unpaid income taxes and $968,000 of interest and penalties. Management, along with its legal counsel, assessed the possible outcomes for this tax audit and believes, based on discussions with its attorneys located in Mexico, that the most likely outcome will be that the Company will be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at December 31, 2023 or December 31, 2022 relating to this potential tax liability.

In March 2024, the Company received a favorable ruling from its appeal with no assessment due related to this audit of USAMSA’s 2013 income tax return by SAT. This ruling supports the Company’s position on this tax matter and had no impact on the Company’s financial statements at March 31, 2024 or December 31, 2023. Mexico’s lower court will issue a final ruling on this matter as to whether this decision can be appealed by the appropriate Mexican authorities.

Mexico Value Added Tax

USAMSA records a receivable for the Value Added Tax (“VAT” or “IVA”) it pays on certain goods and services representing amounts to be reimbursed from the Mexican government. USAMSA has a reserve of $717,647 and $687,534 on its IVA receivable balance at March 31, 2024 and December 31, 2023, respectively. The net IVA receivable of $470,083 and $435,094 at March 31, 2024 and December 31, 2023, respectively, is recorded in “IVA receivable and other assets, net” in assets held for sale in discontinued operations.

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2024

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Reclassifications

Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. 

Discontinued Operations

Disposal groups that meet the discontinued operations criteria by the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 205-20-45 are classified as discontinued operations and are excluded from continuing operations and segment results for all periods presented.

Share-Based Compensation

The Company’s share-based awards consist of restricted stock units (“RSUs”) and stock options granted to employees and non-employee directors.

RSUs are stock awards entitling the award recipient to a specified number of shares of the Company’s common stock as the award vests. Each of our RSU grants include a time-based vesting condition, which is the only vesting condition related to the RSU grants. The Company calculates the fair value of RSUs on the grant date using the closing market price of the Company’s common stock on the grant date. The Company expenses the grant date fair value of RSUs ratably over the requisite service period, other than RSUs that vest on the grant date, the grant date fair value of which is expensed on the grant date. The Company recognizes forfeitures as they occur.

Stock options grant award recipients the option to purchase a specified number of shares of the Company’s common stock at an exercise price per share specified in the grant agreement as the stock options vest. Stock option grants include either a time-based vesting condition or performance-based vesting conditions with a specified term to meet the performance condition. The Company calculates the fair value of stock options on the grant date using the Black-Scholes option-pricing model, which requires the Company to make estimates and assumptions, such as expected volatility, expected term, and risk-free interest rate. For time-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably over the requisite service period. For performance-based vesting stock option grants, the Company expenses the grant date fair value of the award based on the probability and timing of achieving the performance criteria. The Company recognizes forfeitures as they occur.

The expense related to employee and non-employee director share-based awards is recorded in “Salaries and benefits” and “General and administrative,” respectively, in the Condensed Consolidated Statements of Operations.

New Accounting Pronouncements

Management does not believe that any recently issued but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, amending reportable segment disclosure requirements to include disclosure of incremental segment information on an annual and interim basis. Among the disclosure enhancements are new disclosures regarding significant segment expenses that are regularly provided to the chief operating decision-maker and included within each reported measure of segment profit or loss, as well as other segment items bridging segment revenue to each reported measure of segment profit or loss. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, and are applied retrospectively. Early adoption is permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. We are currently evaluating the impact of this update on our consolidated financial statements and disclosures. 

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2024

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

Antidilutive securities excluded from computation of earnings per share

	March 31, 2024		March 31, 2023
Warrants		12,346,215		12,346,215
RSUs		225,695		-
Total possible dilution		12,571,910		12,346,215

XML

REVENUE RECOGNITION (Tables)

3 Months Ended

Mar. 31, 2024

REVENUE RECOGNITION

Disaggregation of Revenue

	For the three months ended
	March 31, 2024		March 31, 2023
Antimony product revenue	$	2,228,385	$	1,612,639
Zeolite product revenue		603,005		482,093
Precious metals product revenue		-		116,112
TOTAL REVENUES	$	2,831,390	$	2,210,844

Revenue by Geographic Area

	For the three months ended
	March 31, 2024		March 31, 2023
Domestic revenues	$	2,280,774	$	1,991,230
Foreign revenues		550,616		219,614
TOTAL REVENUES	$	2,831,390	$	2,210,844

XML

INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2024

INVENTORIES

Schedule of Inventory Current

	March 31, 2024		December 31, 2023
Antimony oxide inventory	$	136,245	$	252,927
Antimony metal inventory		90,631		237,429
Antimony ore and concentrates inventory		24,482		23,752
Total antimony inventory		251,358		514,108
Zeolite inventory		401,652		505,046
TOTAL INVENTORIES	$	653,010	$	1,019,154

XML

PROPERTIES PLANTS AND EQUIPMENT (Tables)

3 Months Ended

Mar. 31, 2024

PROPERTIES PLANTS AND EQUIPMENT

Major components of property, plant and equipment

March 31, 2024	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,368,804		$	234,174		$	7,357,423
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			18,590			-			18,590
PP&E, gross	$	4,645,890		$	1,420,958		$	8,100,076		$	234,174		$	14,401,098
Accumulated depreciation		(2,675,660	)		(239,047	)		(3,597,180	)		(179,399	)		(6,691,286	)
PP&E, net	$	1,970,230		$	1,181,911		$	4,502,896		$	54,775		$	7,709,812

December 31, 2023	Antimony Segment						Zeolite Segment			Precious Metals
	USAC			Mexico			BRZ			Segment			TOTAL
Plant and equipment	$	1,675,444		$	79,001		$	5,336,808		$	234,174		$	7,325,427
Buildings		243,248			11,970			2,025,043			-			2,280,261
Land and other		2,727,198			1,329,987			687,639			-			4,744,824
Construction in progress		-			-			8,951			-			8,951
PP&E, gross	$	4,645,890		$	1,420,958		$	8,058,441		$	234,174		$	14,359,463
Accumulated depreciation		(2,661,719	)		(235,024	)		(3,524,130	)		(173,545	)		(6,594,418	)
PP&E, net	$	1,984,171		$	1,185,934		$	4,534,311		$	60,629		$	7,765,045

XML

DEBT (Tables)

3 Months Ended

Mar. 31, 2024

DEBT

Schedule of Long-term debt

	March 31, 2024			December 31, 2023
Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck	$	7,170		$	28,443
Total debt		7,170			28,443
Less current portion of debt		(7,170	)		(28,443	)
Long term portion of debt	$	-		$	-

XML

STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Mar. 31, 2024

STOCKHOLDERS' EQUITY

Stock options

	Stock Options			Stock Options
	Granted On			Granted On
	January 29, 2024			March 1, 2024
Fair value per share of options granted	$	0.24		$	0.16
Options granted		200,000			3,400,000
Exercise price per share	$	0.25		$	0.22
Expected Term (in years)		10			3
Risk-free rate		4.08	%		4.32	%
Volatility		302.65	%		116.28	%

Warrants outstanding

Number of warrants		Exercise Price		Expiration Date	Remaining life (years)
	2,285,715	$	0.46	7/31/2025		1.33
	804,000	$	0.46	1/27/2026		1.83
	7,650,000	$	0.85	8/3/2026		2..34
	1,606,500	$	0.85	2/1/2026		1.84
	12,346,215

XML

BUSINESS SEGEMENTS (Tables)

3 Months Ended

Mar. 31, 2024

BUSINESS SEGEMENTS

Segment information

Total Assets, Excluding Discontinued Operations	March 31, 2024		December 31, 2023
Antimony segment:
United States total assets	$	14,962,876	$	14,769,408
Mexico total assets		1,248,036		1,211,319
Subtotal antimony segment	$	16,210,912	$	15,980,727
Precious metals segment:
United States total assets	$	86,864	$	92,718
Mexico total assets		-		-
Subtotal precious metals segment	$	86,864	$	92,718
Zeolite segment		5,276,627		5,474,010
Total assets, excluding discontinued operations	$	21,574,403	$	21,547,455

Summary of capital expenditure

Capital expenditures, Excluding Discontinued Operations	For the three months ended
	March 31, 2024		March 31, 2023
Antimony segment:
United States capital expenditures	$	-	$	3,550
Mexico capital expenditures		-		-
Subtotal antimony segment	$	-	$	3,550
Precious metals segment		-		-
Zeolite segment		52,713		497,652
Total capital expenditures, excluding discontinued operations	$	52,713	$	501,202

Summary of segement operation

Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2024	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	2,228,385	$	-	$	2,228,385	$	-	$	603,005	$	2,831,390
Depreciation and amortization		13,941		4,024		17,965		5,854		82,328		106,147
Income (loss) from operations	$	394,806	($26,197)		$	368,609	($5,854)		($431,501)		(68,746)
Other income												154,847
Income tax expense												-
NET INCOME											$	86,101
Segment Operations, Excluding Discontinued Operations	Antimony		Antimony		Total		Precious
For the three months ended March 31, 2023	USA		Mexico		Antimony		Metals		Zeolite		Total
Total revenues	$	1,612,639	$	-	$	1,612,639	$	116,112	$	482,093	$	2,210,844
Depreciation and amortization		8,280		4,024		12,304		5,854		51,174		69,332
Income (loss) from operations	$	62,072	($27,849)		$	34,223	$	110,258	($64,605)		$	79,876
Other income												213,505
Income tax expense												-
NET INCOME											$	293,381

XML

DISCONTINUED OPERATIONS (Table)

3 Months Ended

Mar. 31, 2024

BUSINESS SEGEMENTS

Loss from discontinued operations

	For the three months ended
	March 31, 2024			March 31, 2023
REVENUES	$	240,677		$	-
COST OF REVENUES		474,096			930,262
GROSS PROFIT LOSS		(233,419	)		(930,262	)
OPERATING EXPENSES:
General and administrative		44,892			14,323
Professional fees		35,151			38,802
Other operating expenses		88,246			108,345
TOTAL OPERATING EXPENSES		168,289			161,470
LOSS FROM OPERATIONS		(401,708	)		(1,091,732	)
OTHER EXPENSE:
Other miscellaneous expense		(7,161	)		(8,633	)
TOTAL OTHER EXPENSE		(7,161	)		(8,633	)
LOSS FROM DISCONTINUED OPERATIONS BEFORE TAX		(408,869	)		(1,100,365	)
Income tax expense		-			-
LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX	$	(408,869	)	$	(1,100,365	)

Assets and liabilities of discontinued operations

	March 31, 2024		December 31, 2023
ASSETS
CURRENT ASSETS
Inventories, net	$	215,110	$	366,955
Total current assets, discontinued operations		215,110		366,955
Properties, plants and equipment, net		5,689,446		5,689,446
IVA receivable and other assets, net		526,128		491,139
Total assets, discontinued operations	$	6,430,684	$	6,547,540
LIABILITIES
CURRENT LIABILITIES
Accounts payable	$	137,744	$	126,788
Accrued liabilities		20,359		24,500
Total current liabilities, discontinued operations		158,103		151,288
Asset retirement obligations		536,466		536,466
Total liabilities, discontinued operations	$	694,569	$	687,754

XML

EARNINGS PER SHARE (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
TOTAL POSSIBLE DILUTIVE SHARES	$ 12,571,910	$ 12,346,215
Convertible Preferred Stock [Member]
TOTAL POSSIBLE DILUTIVE SHARES	225,695
Warrants [Member]
TOTAL POSSIBLE DILUTIVE SHARES	12,346,215	12,346,215

XML

REVENUE RECOGNITION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUE	$ 2,831,390	$ 2,210,844
Antimony [Member]
REVENUE	2,228,385	1,612,639
Zeolite [Member]
REVENUE	603,005	482,093
Precious Metals [Member]
REVENUE	$ 0	$ 116,112

XML

REVENUE RECOGNITION (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUE	$ 2,831,390	$ 2,210,844
Domestic revenues [Member]
REVENUE	2,280,774	1,991,230
Foreign revenues [Member]
REVENUE	$ 550,616	$ 219,614

XML

REVENUE RECOGNITION (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
REVENUE RECOGNITION
Trade accounts receivable balance related to contracts with customers	$ 1,057,742	$ 625,256
Doubtful related trade accounts receivables	$ 271,212	$ 271,212

XML

INVENTORIES (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventories	$ 653,010	$ 1,019,154
Antimony Metals [Member]
Inventories	90,631	237,429
Antimony Oxides [Member]
Inventories	136,245	252,927
Antimony Ore Concentrates [Member]
Inventories	24,482	23,752
Zeolite Products [Member]
Inventories	401,652	505,046
Antimony [Member]
Inventories	$ 251,358	$ 514,108

XML

INVENTORIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
INVENTORIES
Write down of inventory to net realizable value	$ 80,143	$ 0

XML

PROPERTIES PLANTS AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Plant and equipment	$ 7,357,423	$ 7,325,427
Buildings	2,280,261	2,280,261
Land and other	4,744,824	4,744,824
Construction in progress	18,590	8,951
Plants and equipment net	14,401,098	14,359,463
Accumulated Deprecation	(6,691,286)	(6,594,418)
Property plant and equipment ,net	7,709,812	7,765,045
Antimony Segment USAC [Member]
Plant and equipment	1,675,444	1,675,444
Buildings	243,248	243,248
Land and other	2,727,198	2,727,198
Construction in progress	0
Plants and equipment net	4,645,890	4,645,890
Accumulated Deprecation	(2,675,660)	(2,661,719)
Property plant and equipment ,net	1,970,230	1,984,171
Zeolite Segment BRZ [Member]
Plant and equipment	5,368,804	5,336,808
Buildings	2,025,043	2,025,043
Land and other	687,639	687,639
Construction in progress	18,590	8,951
Plants and equipment net	8,100,076	8,058,441
Accumulated Deprecation	(3,597,180)	(3,524,130)
Property plant and equipment ,net	4,534,311	4,534,311
Precious Metals Segment [Member]
Plant and equipment	234,174	234,174
Buildings	0	0
Land and other	0	0
Construction in progress	0	0
Plants and equipment net	234,174	234,174
Accumulated Deprecation	(179,399)	(173,545)
Property plant and equipment ,net	54,775	60,629
Antimony Segment Mexico [Member]
Plant and equipment	79,001	79,001
Buildings	11,970	11,970
Land and other	1,329,987	1,329,987
Construction in progress	0
Plants and equipment net	1,420,958	1,420,958
Accumulated Deprecation	(239,047)	(235,024)
Property plant and equipment ,net	$ 1,181,911	$ 1,185,934

XML

LONG-TERM DEBT (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Long term debt	$ 7,170	$ 28,443
Less current portion	(7,170)	(28,443)
Long term portion	0	0
Caterpillar Financial Services [Member]
Long term debt	$ 7,170	$ 28,443

XML

LONG-TERM DEBT (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
DEBT
Long term debt	$ 7,170	$ 28,443

XML

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Accrued royalties payable	$ 52,527	$ 153,429
Minimum [Member]
Royalties vary	8.00%
Maximum [Member]
Royalties vary	13.00%

XML

STOCKHOLDERS EQUITY (Details) - $ / shares		1 Months Ended
	Mar. 01, 2023	Jan. 29, 2024	Mar. 01, 2024
STOCKHOLDERS' EQUITY
Fair value per share of options granted	$ 0.16	$ 0.24
Exercise price per share		$ 0.25	$ 0.22
Options granted	3,400,000	200,000
Expected Term (in years)	3 years	10 years
Risk-free rate	4.32%	4.08%
Volatility	116.28%	302.65%

XML

STOCKHOLDERS EQUITY (Details 1)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Warrant 1
Number of warrants	2,285,715
Exercise Price | $ / shares	$ 0.46
Remaining life	1 year 3 months 29 days
Expiration date	Jul. 31, 2025
Warrant 2
Number of warrants	804,000
Exercise Price | $ / shares	$ 0.46
Remaining life	1 year 9 months 29 days
Expiration date	Jan. 27, 2026
Warrant 3
Number of warrants	7,650,000
Exercise Price | $ / shares	$ 0.85
Remaining life	2 years 4 months 2 days
Expiration date	Aug. 03, 2026
Warrant 4
Number of warrants	1,606,500
Exercise Price | $ / shares	$ 0.85
Remaining life	1 year 10 months 2 days
Expiration date	Feb. 01, 2026
Warrants [Member]
Number of warrants	12,346,215

XML

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended
	Mar. 01, 2023	Jan. 29, 2024	Jan. 26, 2023	Mar. 31, 2024	Dec. 31, 2023	Jan. 25, 2023	Dec. 31, 2022
Cash paid to shareholders						$ 787,730
Description of returned of shares			the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980
Dividend paid				$ 740,261
Options granted	3,400,000	200,000
Preferred stock, issued shares						1,692,672
Preferred stock, authorized shares				10,000,000	10,000,000		100,000
Board Of Directors [Member]
Options granted		200,000
Unrecognized compensation expense		$ 22,667		$ 333,819
Description				The fair value of the RSUs granted on January 29, 2024 was $24,000 and the fair value of the stock options granted on January 29, 2024 was $48,000. The Company’s Board of Directors also granted 2,375,000 RSUs and 3,400,000 stock options to employees and non-employee directors on March 1, 2024 with the RSUs vesting one-third each year beginning on the grant date, 2,500,000 stock options vesting one-third each year beginning each anniversary subsequent to the grant date, and 900,000 stock options with performance-based vesting conditions and a 3-year term. The fair value of the RSUs granted on March 1, 2024 was $522,500 and the fair value of the stock options granted on March 1, 2024 was $544,000. One-third of the RSUs granted on March 1, 2024, which equates to 791,667 shares of the Company’s common stock, vested during the three months ended March 31, 2024. At March 31, 2024, 1,583,333 RSU’s are unvested from the March 1, 2024 grant and 100,000 RSUs are unvested from the January 29, 2024 grant. The Company expensed $205,925 and $nil during the three months ended March 31, 2024 and 2023, respectively, related to stock option and RSU grant
Remaning Unrecognized compensation expense		$ 528,889
Remaining life		2 years 11 months 1 day		2 years 9 months 29 days
Board Of Directors One [Member]
Unrecognized compensation expense		$ 47,200		$ 102,000
Remaining life		8 years 3 months 29 days		2 years 11 months 1 day
Preferred Stock D Series [Member]
Cash paid to shareholders						$ 787,730
Number of shares converted						1,590,672
Preferred stock, issued shares						1,692,672
Preferred stock, authorized shares		1,000,000
Number of shares converted amount			$ 740,261
Total Series D Preferred stock shares						1,692,672

XML

Business Segments (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Total assets	$ 21,574,403	$ 21,547,455
Mexico Antimony [Member]
Total assets	1,248,036	1,211,319
United States Antimony [Member]
Total assets	14,962,876	14,769,408
Subtotal Antimony [Member]
Total assets	16,210,912	15,980,727
United States Precious Metals [Member]
Total assets	86,864	92,718
Mexico Precious Metals [Member]
Total assets	0	0
Subtotal Precious Metals [Member]
Total assets	86,864	92,718
Zeolite [Member]
Total assets	$ 5,276,627	$ 5,474,010

XML

Business Segments (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Capital expenditures	$ 52,713	$ 501,202
Mexico Antimony [Member]
Capital expenditures	0	0
United States Antimony [Member]
Capital expenditures	0	3,550
Subtotal Antimony [Member]
Capital expenditures	0	3,550
Subtotal Precious Metals [Member]
Capital expenditures	0	0
Zeolite [Member]
Capital expenditures	$ 52,713	$ 497,652

XML

Business Segments (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUE	$ 2,831,390	$ 2,210,844
Depreciation and amortization	106,147	69,332
Income (loss) from operations	(68,746)	79,876
Other income (expense)	154,847	213,505
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	86,101	293,381
Net income (loss)	86,101	293,381
Mexico Antimony [Member]
REVENUE	0	0
Depreciation and amortization	4,024	4,024
Income (loss) from operations	(26,197)	(27,849)
Other income (expense)	0	0
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	0	0
Net income (loss)	0	0
United States Antimony [Member]
REVENUE	2,228,385	1,612,639
Depreciation and amortization	13,941	8,280
Income (loss) from operations	(394,806)	(62,072)
Other income (expense)	0	0
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	0	0
Net income (loss)	0	0
Total Antimony [Member]
REVENUE	2,228,385	1,612,639
Depreciation and amortization	17,965	12,304
Income (loss) from operations	(368,609)	(34,223)
Other income (expense)	0	0
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	0	0
Net income (loss)	0	0
Zeolite [Member]
REVENUE	603,005	482,093
Depreciation and amortization	82,328	51,174
Income (loss) from operations	(431,501)	(64,605)
Other income (expense)	0	0
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	0	0
Net income (loss)	0	0
Precious Metals [Member]
REVENUE	0	116,112
Depreciation and amortization	5,854	5,854
Income (loss) from operations	(5,854)	110,258
Other income (expense)	0	0
Total income tax expense	0	0
INCOME FROM CONTINUING OPERATIONS	0	0
Net income (loss)	$ 0	$ 0

XML

Discontinued operations (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUE	$ 2,831,390	$ 2,210,844
COST OF REVENUES	2,008,486	1,816,001
GROSS PROFIT (LOSS)	822,904	394,843
General and administrative	455,394	141,271
Professional fees	177,157	46,004
TOTAL OPERATING EXPENSES	891,650	314,967
INCOME (LOSS) FROM OPERATIONS	(68,746)	79,876
Other miscellaneous income (expense)	(2,372)	83,608
TOTAL OTHER INCOME (EXPENSE)	154,847	213,505
INCOME (LOSS) BEFORE INCOME TAX	(408,869)	(1,100,365)
Income tax expense	0	0
Discontinue Operation [Member]
REVENUE	240,677	0
COST OF REVENUES	474,096	930,262
GROSS PROFIT (LOSS)	(233,419)	(930,262)
General and administrative	44,892	14,323
Professional fees	35,151	38,802
Other operating expenses	88,246	108,345
TOTAL OPERATING EXPENSES	168,289	161,470
INCOME (LOSS) FROM OPERATIONS	(401,708)	(1,091,732)
Other miscellaneous income (expense)	(7,161)	(8,633)
TOTAL OTHER INCOME (EXPENSE)	(7,161)	(8,633)
INCOME (LOSS) BEFORE INCOME TAX	(408,869)	(1,100,365)
Income tax expense	0	0
LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX	$ (408,869)	$ (1,100,365)

XML

Discontinued operations (Details 1) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventories, net	$ 653,010	$ 1,019,154
Total current assets, discontinued operations	14,006,543	14,076,206
Properties, plants and equipment, net	7,709,812	7,765,045
Total assets	28,005,087	28,094,995
Accounts payable	403,441	330,147
Accrued liabilities	117,822	109,341
Total current liabilities	906,122	897,458
Asset retirement obligations and accrued reclamation costs	1,119,832	1,101,561
Total liabilities	2,600,962	2,574,027
Discontinue Operation [Member]
Inventories, net	215,110	366,955
Total current assets, discontinued operations	215,110	366,955
Properties, plants and equipment, net	5,689,446	5,689,446
IVA receivable and other assets	526,128	491,139
Total assets	6,430,684	6,547,540
Accounts payable	137,744	126,788
Accrued liabilities	20,359	24,500
Total current liabilities	158,103	151,288
Asset retirement obligations and accrued reclamation costs	536,466	536,466
Total liabilities	$ 694,569	$ 687,754

XML

Discontinued operations (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Nov. 30, 2019	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Depreciation and amortization		$ 106,147	$ 69,332
Discontinue Operation [Member]
Inventories, net		43,074		$ 246,792
Depreciation and amortization		0	154,909
Capital expenditures		0	$ 113,568
Asset retirement obligations and accrued reclamation costs		0		2,993
Total Income tax	$ 795,000	666,400		1,320,000
Mexican Tax Authority [Member]
Income tax	$ 16,300,000	13,800,000		22,400,000
Unpaid income taxes				352,000
Interest and penalties amount				968,000
Value Added Tax receivable amount		717,647		687,534
Value Added Tax receivable Net		$ 470,083		$ 435,094